etoposide has been researched along with mitomycin in 245 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (11.84) | 18.7374 |
| 1990's | 120 (48.98) | 18.2507 |
| 2000's | 74 (30.20) | 29.6817 |
| 2010's | 21 (8.57) | 24.3611 |
| 2020's | 1 (0.41) | 2.80 |
| Authors | Studies |
|---|---|
| Hansch, C; Khwaja, TA; Selassie, CD | 1 |
| Barrows, LR; Ireland, CM; Kokoshka, JM | 1 |
| Chen, LJ; Ding, J; Li, M; Lu, LJ; Tang, QM; Yuan, ST; Zhang, JS; Zhao, M | 1 |
| Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Benfenati, E; Raska, I; Toropov, AA; Toropova, AP | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Przybylski, P; Łowicki, D | 1 |
| Thongprasert, S | 1 |
| Cimoli, G; Conte, P; Conzi, G; Noviello, E; Orengo, G; Pagnan, G; Parodi, S; Russo, P; Schenone, F; Venturini, M | 1 |
| Hirano, A; Ohkawa, T; Shinka, T; Uekado, Y | 1 |
| Saini, A; Waxman, J | 1 |
| Fushida, S; Kaji, M; Kosaka, T; Matsumoto, H; Muraoka, K; Nakai, M; Segawa, M; Takano, Y; Tsugawa, K; Yonemura, Y | 1 |
| Fukushima, W; Hirosawa, H; Kadoya, N; Konishi, K; Kuroda, Y; Sahara, H; Saitoh, F; Taniya, T; Tsuji, M; Yabushita, K | 1 |
| Kimura, H; Kinoshita, K; Kosaka, T; Miwa, K; Miyazaki, I; Ninomiya, I; Ohyama, S; Tanaka, M; Tsugawa, K; Yonemura, Y | 1 |
| Fushiki, H | 1 |
| Cold, S; Pfeiffer, P; Rose, C | 1 |
| Bandou, H; Kobayashi, T; Mura, T; Nomura, T; Watanabe, K | 1 |
| Demirkazik, A; Dinçol, D; Günel, N; Içli, F; Karaoğuz, H | 1 |
| Gotoda, A; Kamiyama, T; Matsuoka, S; Nagabuchi, E; Nakajima, Y; Saito, M; Uchino, J; Une, Y | 1 |
| Hamano, K; Ihara, H; Imai, S; Kirita, T; Kon, M; Nishiyama, T; Ohchi, T | 1 |
| Airoma, G; Garufi, C; Gebbia, V; Gentile, M; Gridelli, C; Iacobelli, S; Palmeri, S; Palmieri, G; Pepe, R; Russo, A | 1 |
| Gatzemeier, U; Heckmayr, M; Hossfeld, DK; Kaukel, E; Koschel, G; Neuhauss, R | 2 |
| Fukuoka, M; Kudo, S; Masuda, N; Negoro, S; Takada, M | 1 |
| Alonso Muñoz, C; Blanco Guerrero, R; Climent Durán, MA; Germà Lluch, JR; López López, JJ; López Pousa, A; Mercedes Ramírez, A | 1 |
| Ohtagaki, S; Toge, T; Toi, M; Yagi, M; Yoshinaka, K | 1 |
| Endo, Y; Kinoshita, K; Miyazaki, I; Ninomiya, I; Ohyama, S; Sasaki, T; Tanaka, M; Yonemura, Y | 1 |
| Kaneko, M; Kaneko, S; Ohkawa, H | 1 |
| Endo, Y; Kimura, H; Kinoshita, K; Miyazaki, I; Ninomiya, I; Ohyama, S; Sasaki, T; Tanaka, M; Tugawa, K; Yonemura, Y | 1 |
| Niitsu, Y; Saito, K; Sato, M; Takagane, A; Terashima, M; Yokkaichi, H | 1 |
| Hasegawa, Y; Honnma, S; Nakashima, Y; Takanashi, K; Yajima, K | 1 |
| Fujita, F; Fujita, M; Inaba, H; Okuyama, Y; Sugimoto, T; Taguchi, T | 1 |
| Anada, E; Fujimura, T; Fujita, H; Haryo, S; Sawasaki, K; Shima, Y; Shiota, S | 1 |
| Kato, M; Kinoshita, K; Miwa, K; Ohyama, S; Sawa, T; Segawa, M; Takano, Y; Tomita, F; Yonemura, Y; Yoshimitsu, S | 1 |
| Ishii, S; Itoh, O; Kariya, Y; Kawaharajo, K; Nagasawa, M; Takeuchi, T; Yamamoto, H | 1 |
| Miura, K; Tsukada, T; Yuri, Y | 1 |
| Doyle, TW; Vyas, DM | 1 |
| Imamura, Y; Masuda, T; Matsushita, K; Ohno, S; Oya, M; Tokisue, M; Yasutake, K; Yoshimura, Y | 2 |
| Imamura, Y; Masuda, T; Matsushita, K; Ono, S; Oya, M; Tokisue, M; Yasutake, K; Yoshimura, Y | 1 |
| Izumi, R; Kobayashi, K; Matsui, O; Miyazaki, I; Shimizu, K; Watanabe, T | 1 |
| Fukuoka, M; Kubota, K; Kusunoki, Y; Masuda, N; Matsui, K; Negoro, S; Ryu, S; Sakai, N; Takada, M; Takifuji, N | 1 |
| Ballatori, E; Buzzi, F; Corgna, E; Crino, L; Darwish, S; Di Costanzo, F; Fornari, G; Meacci, ML; Santi, E; Tonato, M | 1 |
| Fukuoka, M; Furuse, K; Kawahara, M; Masuda, N; Matsui, K; Negoro, S; Takada, M; Takifuji, N | 1 |
| Fujimura, T; Hasegawa, K; Kato, M; Kinoshita, K; Miyata, T; Ohyama, S; Sawa, T; Takekawa, S; Ueda, N; Watanabe, T | 1 |
| Fujita, J; Saijo, N | 1 |
| Bodet, CA; Drutz, DJ; Jorgensen, JH | 1 |
| Raffin, TA; Sikic, BI; Yamauchi, T; Yang, P | 1 |
| Cellerino, R; Menichetti, ET; Miseria, S; Silva, RR; Torresi, U; Tummarello, D | 1 |
| Imamura, Y; Matsusita, K; Okutani, T; Ono, S; Oya, M; Tokisue, M; Yasutake, K; Yoshimura, Y | 1 |
| Coffman, FD; Godwin, A; Green, LM; Ware, CF | 1 |
| Ihde, DC; Viallet, J | 1 |
| Chahinian, AP; Comis, RL; Hirsh, V; Holland, JF; Kopel, S; Perry, MC; Propert, KJ; Skarin, A; Ware, JH; Zimmer, B | 1 |
| Eguchi, K; Fujiwara, Y; Kojima, A; Minato, K; Nakagawa, K; Nakajima, T; Saijo, N; Sasaki, Y; Shinkai, T; Tamura, T | 1 |
| Covey, JM; Kao-Shan, CS; Kerrigan, D; Pommier, Y; Whang-Peng, J | 1 |
| Ballatori, E; Buzzi, F; Corgna, E; Crinó, L; Darwish, S; Di Costanzo, F; Fornari, G; Luccioli, L; Meacci, ML; Santi, F | 1 |
| Livingston, RB | 1 |
| Chak, LY; Cox, RS; Kushlan, PD; Porzig, KJ; Sikic, BI; Wasserstein, P; Zatz, LM | 1 |
| Fukuda, Y; Homma, T; Nakata, M; Noguchi, Y; Yoneda, S; Yoshida, S | 1 |
| Arraztoa, J; Orlandi, L; Ramírez, G; Rodríguez, R; Vogel, C | 1 |
| Hino, K; Ibaraki, T; Katou, Y; Kiyozuka, Y; Maruyama, M; Nabuchi, K; Ninomiya, Y; Noda, T; Okamura, Y; Oku, M | 1 |
| Fukuoka, M; Kusunoki, Y; Masuda, N; Matsui, K; Negoro, S; Ryu, S; Sakai, N; Takada, M; Takifuji, N; Tsubura, E | 1 |
| Schurig, JE; Stringfellow, DA | 1 |
| Creech, RH; Ettinger, DS; Finkelstein, DM; Joss, RA; Mason, BA; Ruckdeschel, JC; Vogl, S | 1 |
| Ettinger, DS; Finkelstein, DM; Ruckdeschel, JC | 1 |
| Eguchi, K; Fujita, J; Futami, H; Kimata, M; Saijo, N; Sasaki, Y; Shimizu, E; Shinkai, T; Takahashi, K; Tominaga, K | 1 |
| Biasioli, R; Lombardi, F; Riundi, R; Scanni, A; Tomirotti, M | 1 |
| Klastersky, J; Sculier, JP | 1 |
| Uchibayashi, T | 1 |
| Kelsen, D | 1 |
| Eguchi, K; Saijo, N; Sasaki, Y; Seki, S; Shimizu, E; Shinkai, T; Takahashi, K; Tominaga, K | 1 |
| Chahinian, AP; Green, G; Holland, JF | 1 |
| Alburquerque Carbuccia, H; Madrigal Alonso, PL; Perez Manga, G | 1 |
| Demachi, H; Konishi, K; Kuroda, Y; Tsugawa, K; Tsuji, M; Yabushita, K | 1 |
| Aluigi, MG; Cimoli, G; De Sessa, F; Mazzoni, A; Noviello, E; Parodi, S; Rovini, E; Russo, P | 1 |
| Hayakawa, O; Kudo, R; Takehara, M | 1 |
| Baroni, C; Bonsignore, G; Ciriaco, P; Cortesi, E; De Giacomo, T; Della Rocca, G; Flaishman, I; Rendina, EA; Ricci, C; Venuta, F | 1 |
| Barduagni, M; Carlini, P; Carpi, A; Ceci, G; Clerici, M; Cortesi, E; Crinò, L; Di Costanzo, F; Figoli, F; Santini, A | 1 |
| Jaspers, NG; Jongmans, W; Lohman, PH; Morolli, B; van der Schans, GP; Verhaegh, GW; Zdzienicka, MZ | 1 |
| Bizjak, L; Jernej, B; Kapitanović, S; Osmak, M | 1 |
| Fujimura, T; Fujita, H; Fushida, S; Hirono, Y; Itoh, H; Kaji, M; Kinami, S; Nakagawara, H; Nakai, M; Yonemura, Y | 1 |
| Aizawa, K; Hatakeyama, K; Muto, I; Nishimaki, T; Suzuki, S; Suzuki, T; Tanaka, N; Tanaka, O; Yabusaki, H | 1 |
| Boni, C; Carlini, P; Carpi, A; Ceci, G; Clerici, M; Cortesi, E; Crinò, L; Di Costanzo, F; Figoli, F; Santini, A | 1 |
| Ichikawa, G; Inuyama, Y; Kawaida, M; Kohno, N; Ohnuma, T; Shirasaka, T | 1 |
| Kohno, K; Kuwano, M; Makino, Y; Nanri, H; Ohga, T; Okamoto, T; Ono, M; Wada, M; Yodoi, J; Yokomizo, A | 1 |
| Ichikawa, G; Kohno, N; Kusunoki, M; Nakazawa, E; Nishiya, M | 1 |
| Adel, AL; Dorr, RT; Liddil, JD | 1 |
| Biller, H; Fujii, M; Holland, JF; Ohnuma, T; Okabe, M; Szrajer, L | 1 |
| Kaneko, Y; Tsukamoto, A | 1 |
| Ando, M; Eguchi, K; Katsumata, N; Maeda, M; Ohe, Y; Oshita, F; Shinkai, T; Shiraishi, J; Tamura, T; Yamamoto, N | 1 |
| Hara, K; Iwasaka, T; Matsuo, N; Mvula, M; Nakao, Y; Sugimori, H; Yamasaki, F; Yokoyama, M | 1 |
| Kawai, K; Kawasaki, S; Maruyama, S; Misumi, T; Morokoshi, Y; Murakami, M; Nagai, K; Soda, M; Yamamoto, M; Yosizane, K | 1 |
| Beketić-Oresković, L; Osmak, M | 1 |
| Kawai, K; Kawasaki, S; Maruyama, S; Morokoshi, Y; Murakami, M; Nagai, K; Soda, M; Yamamoto, M; Yoshizane, K | 1 |
| Wakui, A | 1 |
| Broder, LE; Charyulu, KN; Donnelly, EJ; Rao, RK; Raub, WA; Saldana, MJ; Selawry, OS; Sridhar, KS | 1 |
| Horichi, H; Kumaki, T; Matsuki, N; Shima, K; Tajima, H; Takeda, T | 1 |
| Airoma, G; Bianco, AR; Gridelli, C; Incoronato, P; Palazzolo, G; Pepe, R; Rossi, A | 1 |
| Elliott, WL; Howard, CT; Leopold, WR; Roberts, BJ | 1 |
| Akita, Y; Anzai, K; Arai, K; Ishii, M; Itoh, T; Kawada, T; Kawamura, M; Mitamura, K; Nishida, H; Onuki, M | 1 |
| Kallio, M; Lähdetie, J | 1 |
| Akiyama, T; Kiriyama, M; Kita, I; Kosaka, T; Nakagawa, T; Nakano, Y; Saito, H; Takano, Y; Takashima, S; Tomita, F | 1 |
| Blanchard, R; Caguioa, PB; Carney, D; DiMartino, N; Hesketh, A; Hesketh, PJ; Tansan, S | 1 |
| Abe, T; Imaizumi, M; Kojima, H; Nakagawaji, K; Tokumaru, T; Uchida, T | 1 |
| Kato, M; Kinoshita, K; Matsui, H; Miyazaki, I; Sawa, T; Takano, Y; Tomita, F; Yonemura, Y; Yoshimitsu, S | 1 |
| Köpf-Maier, P; Sass, G | 1 |
| Hasegawa, S; Koga, H; Kotoh, S; Kumazawa, J; Kuwano, M; Naito, S; Yokomizo, A | 1 |
| Angelsen, V; Norum, J | 1 |
| Block, T; Depenbrock, H; Fellbaum, C; Hanauske, AR; Peter, R; Rastetter, J; Wenger, M | 1 |
| Abo, K; Hasegawa, H; Horita, K; Nakanishi, Y; Nakashima, T; Nishisaki, H; Oya, M; Yasutake, K; Yoshida, R | 1 |
| Hasumi, K; Shimizu, Y; Umezawa, S | 1 |
| Aikawa, K; Irisawa, C; Ishibashi, K; Ishiwata, H; Koseki, K; Ogihara, M; Shiraiwa, Y | 1 |
| Creus, A; Marcos, R; Ribas, G; Xamena, N | 1 |
| Tanimura, H; Yamaue, H | 1 |
| Fujimura, T; Fushida, S; Hirono, Y; Kawamura, T; Kinami, S; Minami, M; Miwa, K; Miyazaki, I; Nishimura, G; Noguchi, M; Nojima, N; Sato, T; Shiobara, S; Yonemura, Y | 1 |
| Hayashi, N; Ikeba, K; Kinoshita, K; Ohokubo, T; Sodemoto, T; Takagi, A; Takeda, S; Yamamoto, T | 1 |
| Brandt, A; Palmer, AJ | 1 |
| Airoma, G; Bianco, AR; Cognetti, F; D'Aprile, M; De Placido, S; Gallo, C; Gebbia, V; Gridelli, C; Incoronato, P; Leonardi, V; Natali, M; Palazzolo, G; Palmeri, S; Pepe, R; Perrone, F; Rossi, A; Russo, A; Scinto, AF; Veltri, E | 1 |
| Hirono, T; Hirosawa, H; Izumi, R; Kadoya, N; Konishi, I; Ohta, N; Saito, K; Ueda, N; Yoshimitsu, Y | 1 |
| Hoskins, PJ; Lee, N; McMurtrie, EM; Pike, JA; Swenerton, KD | 1 |
| Oka, T; Sawabe, Y; Yamagishi, H; Yamaguchi, N; Yamamura, Y | 1 |
| Beesley, JS; Hamilton, TC; Johnson, SW; Laub, PB; Ozols, RF | 1 |
| Cowan, KH; Fukuda, M; Ikeda, K; Kohno, S; Matsuo, I; Nakano, R; Narasaki, F; Oka, M; Soda, H; Takatani, H; Terashi, K; Tomonaga, M | 1 |
| Bleicher, RJ; Gupta, V; Singh, SV; Xia, H; Zaren, HA | 1 |
| Hanada, R; Hongo, T; Horikoshi, Y; Sakurai, M; Yajima, S | 1 |
| Aoki, K; Kasai, M; Katayanagi, K; Matsuzaki, T; Maziarz, RT; Omori, A; Strominger, JL; Suzuki, K | 1 |
| Boardman, P; Braybrooke, JP; Ganesan, TS; Harris, AL; O'Byrne, KJ; Propper, DJ; Salisbury, AJ; Saunders, MP; Talbot, DC; Taylor, M | 1 |
| Bergman, AM; Guechev, A; Peters, GJ; Postmus, PE; van Moorsel, CJ; Veerman, G; Vermorken, JB | 1 |
| Li, JH | 1 |
| Kimura, H; Momiki, S; Obata, S; Ogawa, T; Urabe, N; Yamaguchi, Y | 1 |
| Aikawa, K; Ishibashi, K; Koseki, K; Ogihara, M; Shiraiwa, Y; Yamaguchi, O | 1 |
| Baltaci, S; Beksac, M; Küpeli, B; Küpeli, S; Süzer, O | 1 |
| Sakata, Y; Tsushima, K | 1 |
| Chrysanthopoulos, K; Dougenis, D; Ginopoulos, P; Gogos, CH; Kardamakis, D; Onyenadum, A; Solomou, E; Spyropoulos, K | 1 |
| Buckner, JC; Lewis, JE; McElroy, EA | 1 |
| Hirota, S; Hishikawa, Y; Honda, K; Kono, K; Obayasi, K; Soejima, T; Takada, Y; Watanabe, H | 1 |
| Fukuda, K; Hara, K; Iwasaka, T; Nakao, Y; Sugimori, H; Uchiyama, M; Yokoyama, M | 1 |
| Golub, EI; Haaf, T; Raderschall, E | 1 |
| Corey, EJ; Martinez, EJ; Owa, T; Schreiber, SL | 1 |
| Engels, IH; Los, M; Rossmann, E; Schulze-Osthoff, K; Wesselborg, S | 1 |
| Astoul, P; Boutin, C; Kasseyet, S | 1 |
| Bantel, H; Engels, IH; Schulze-Osthoff, K; Voelter, W; Wesselborg, S | 1 |
| Furue, H | 1 |
| Bando, E; Fujimura, T; Fujita, H; Fushida, S; Michiwa, Y; Miwa, K; Nishimura, G; Oyama, K; Taniguchi, K; Yonemura, Y | 1 |
| Hooker, AM; Morley, AA; Sykes, PJ | 1 |
| Eckardt-Schupp, F; Friedl, AA; Jaspers, NG; Klein, B; Kraakman-van der Zwet, M; Lohman, PH; Midro, AT; Overkamp, WJ; Verhaegh, GW; Zdzienicka, MZ | 1 |
| Hirose, K; Iida, A; Katayama, K; Kusaka, Y; Nakagawara, G; Umeda, S; Yamaguchi, A | 1 |
| Chang, WJ; Chen, CH; Liaw, CC; Tsao, TC; Yang, CT | 1 |
| Asano, M; Higashi, S; Hosono, Y; Kane, T; Kato, C; Matsumoto, K; Sakoda, M; Sakumoto, H; Sumiyoshi, K; Takahahsi, T; Takahashi, M; Yamamoto, A | 1 |
| Ichiya, Y; Kuwabara, Y; Maehara, Y; Masuda, K; Nakagawa, M; Sasaki, M; Soeda, H; Sugio, K; Yoshida, T | 1 |
| Bisagni, G; Boni, C; Ceci, G; Cocconi, G; De Lisi, V; Di Blasio, B; Morandi, P; Passalacqua, R; Savoldi, L; Zadro, A | 1 |
| Johnson, MA; Jones, NJ | 1 |
| Kurano, R; Ono, K; Semba, H; Seto, M; Seto, T | 1 |
| Ajisaka, H; Bando, E; Fujimura, T; Fushida, S; Hayashi, T; Minatoya, T; Miwa, K; Nishimura, G; Taniguchi, K; Yonemura, Y | 1 |
| Ali, MA; Cummings, G; Kalemkerian, GP; Kraut, MJ; Valdivieso, M; Wozniak, AJ | 1 |
| Arimoto, J; Bessho, T; Furukawa, T; Hirai, I; Maebeya, S; Matsuyama, K; Naito, Y; Oura, S; Sakurai, T; Suzuma, T; Tanino, H; Yano, T; Yoshimasu, T | 1 |
| Herman, B; Liu, Y; McKalip, A | 1 |
| Kojima, T; Naruse, T; Tokunaga, Y | 1 |
| Barret, JM; Etiévant, C; Hill, BT | 1 |
| Bryant, PE; Johnson, MA; Jones, NJ | 1 |
| Ajani, JA; Yao, JC | 1 |
| Ikari, T; Kano, S; Kawaida, M; Kawaura, M; Kohno, N; Nakamizo, M; Tanaka, K | 1 |
| Booth, D; Feramisco, JR; Fribourg, AF; Hunton, IC; Knudsen, ES; Knudsen, KE; Naderi, S; Sever-Chroneos, Z; Wang, JY | 1 |
| Ikeda, J; Takayasu, Y; Yamamoto, S | 1 |
| Belka, C; Berg, C; Engels, IH; Gregor, M; Jänicke, RU; Lauber, K; Porter, AG; Schulze-Osthoff, K; Schwenzer, R; Stepczynska, A; Stroh, C; Wajant, H; Wesselborg, S | 1 |
| Fujita, T; Hayashi, T; Higashihara, J; Irie, T; Ohishi, Y; Shigematsu, T | 1 |
| Aktoğu, S; Büyükşirin, M; Capa, G; Durak, H; Erkmen, G; Ertay, T; Ozbilek, E; Sayit, E | 1 |
| Kołodziejczyk, P; Kulig, J; Popiela, T | 1 |
| Doddoli, C; Fuentes, P; Giudicelli, R; Papazian, L; Reynaud-Gaubert, M; Thomas, P | 1 |
| Inoue, K; Kasahara, K; Shuin, T | 1 |
| Engels, IH; Janssen, O; Kabelitz, D; Lauber, K; Schulze-Osthoff, K; Stepczynska, A; Wesselborg, S | 1 |
| Appel, HA; Gregor, M; Lauber, K; Schlosser, SF; Schulze-Osthoff, K; Wesselborg, S | 1 |
| Earashi, M; Kobayashi, H; Matsuki, N; Michiwa, Y | 1 |
| Pizzi, MD; Saitoh, H; Wang, J | 1 |
| Kolodziejcyk, P; Kulig, J; Popiela, T | 1 |
| Budd, RC; Ito, M; Kataoka, T; Nagai, K; Tschopp, J | 1 |
| Akeshima, R; Iba, T; Itamochi, H; Kamazawa, S; Kanamori, Y; Kigawa, J; Sultana, H; Terakawa, N | 1 |
| Dobrovolsky, VN; Heflich, RH; Shaddock, JG | 1 |
| Drobchenko, EA; Filatov, MV; Levina, VV; Shabalina, EV; Sukhareva, EB | 1 |
| Furuichi, Y; Goto, M; Hayashi, M; Honma, M; Sakamoto, H; Satoh, T; Sofuni, T; Sugimoto, M; Tadokoro, S; Tanabe, H | 1 |
| Bai, J; Cederbaum, AI | 1 |
| Akiyama, H; Kunisaki, C; Matsuda, G; Nomura, M; Ono, H; Otsuka, Y; Shimada, H | 1 |
| Mornex, F | 1 |
| Liu, J; Tang, WJ; Yu, RC | 1 |
| Duan, P; Wang, ZM | 1 |
| Adler, ID; Attia, SM; Badary, OA; Hamada, FM; Kliesch, U; Schriever-Schwemmer, G | 1 |
| Brega-Massone, PP; Cataldo, I; Conti, B; Ferro, F; Lequaglie, C | 1 |
| Hoshino, H; Saitoh, K; Seki, H; Sodemoto, T; Takada, T; Uekusa, T | 1 |
| Ivanov, S; Zervoudis, S | 1 |
| Akaike, T; Fang, J; Greish, K; Maeda, H; Sawa, T | 1 |
| Fukuda, T; Kohno, K; Kura, S; Kuwano, M; Maehara, Y; Nakabeppu, Y; Shibahara, K; Tominaga, Y; Tsuzuki, T; Uchiumi, T | 1 |
| Fussenegger, M; Fux, C; Gonzalez-Nicolini, V | 1 |
| Al-Hassani, M; Darst, M; Lewis, DA; Li, T; Travers, JB; Travers, JM; Yi, Q | 1 |
| Cejka, P; Jiricny, J; Papouli, E | 1 |
| Nishiura, K; Obata, H; Okugawa, T; Tabata, T; Tanaka, K; Toyoda, N; Yanoh, K | 1 |
| Garriott, ML; Hoffman, WP; Lee, C; Murphy, GP; Phelps, JB | 1 |
| Hirano, T; Kasai, H; Kawai, K; Ootsuyama, Y; Orimo, H | 1 |
| Alaoui-Jamali, MA; Chow, TY; Griller, D; Yeh, C; Yuen, L | 1 |
| Doi, K; Horiuchi, T; Nakamura, T; Okubo, Y; Shimada, K; Tanabe, S; Tanaka, K; Tanaka, S; Uchinami, M; Yoshida, M | 1 |
| Hara, K; Iwasaka, T | 1 |
| Bissler, JJ; Dixon, K; Lu, L; Robison, JG | 1 |
| Bandou, E; Kawamura, T; Matsuki, N; Sawa, T; Takahashi, S; Yonemura, Y | 1 |
| Akazawa, Y; Isomoto, H; Kohno, S; Mizuta, Y; Nakagoe, T; Ohara, H; Ohba, K; Ohnita, K; Omagari, K; Shiozawa, K; Shirono, K; Takeshima, F; Tanaka, K; Yasutake, T | 1 |
| Muehlbauer, PA; Schuler, MJ | 1 |
| Asamura, H; Kodama, T; Kunitoh, H; Matsuno, Y; Ohe, Y; Saijo, N; Sekine, I; Takei, H; Tamura, T; Tsuchiya, R; Yamamoto, N; Yamazaki, S | 1 |
| Brody, JR; Cunningham, SC; DeMarzo, AM; Dezentje, DA; Gallmeier, E; Hruban, RH; Isacoff, WH; Kern, SE; Offerhaus, GJ; Swartz, MJ; van der Heijden, MS | 1 |
| Bai, T; Tanaka, T; Umesaki, N; Yukawa, K | 1 |
| Kroemer, G; Larochette, N; Massard, C; Métivier, D; Pauleau, AL; Sabatier, L; Soria, JC; Zermati, Y | 1 |
| Depierre, A | 1 |
| Atil, H; Aysan, T; Cok, G; Göksel, T; Güzelant, A; Soyer, S | 1 |
| Black, WJ; Day, BJ; Jester, JV; Lassen, N; Min, E; Pappa, A; Vasiliou, V | 1 |
| Doba, S; Funaki, K; Kawashima, A; Kiriyama, M; Kita, T; Kojima, Y; Kurosaka, Y; Michiwa, Y; Sasaki, S; Takekawa, S; Tamura, M | 1 |
| Apetoh, L; Casares, N; Castedo, M; Ciccosanti, F; Fimia, GM; Ghiringhelli, F; Kroemer, G; Larochette, N; Métivier, D; Mignot, G; Obeid, M; Panaretakis, T; Perfettini, JL; Piacentini, M; Tesniere, A; van Endert, P; Zitvogel, L | 1 |
| Ling, MT; Wang, X; Wong, YC; Zhang, X | 1 |
| Clarke, C; Smyth, MJ | 1 |
| Becherel, OJ; Chen, P; de Murcia, G; de Murcia, JM; Epe, B; Fusser, M; Grattan-Smith, P; Gueven, N; Haince, JF; Howe, O; Lavin, MF; McGowan, CH; Mothersill, C; Ouellet, ME; Parton, R; Poirier, GG; Waterhouse, N | 1 |
| Cicconetti, F; Franchi, F; Iascone, C; Ielapi, T; Nigita, G; Pastore, C; Seminara, P | 1 |
| Cho, YH; Hah, JH; Heo, DS; Kim, DW; Kim, KH; Lee, SH; Rhee, CS; Sung, MW; Wu, HG | 1 |
| Czyzewicz, G; Jasiówka, M; Kojs-Pasińska, E; Rolski, J; Zemełka, T | 1 |
| Du, R; Fan, D; Hong, L; Liu, J; Pan, Y; Sun, S; Xia, L; Zhang, D; Zhao, L | 1 |
| Green, AM; Khurgel, M; Kupfer, GM; Mihaylova, VT; Semmes, OJ | 1 |
| Brody, JR; Gallmeier, E; Gorospe, M; Hucl, T; Kern, SE; Rago, C | 1 |
| Caragnano, A; Del Col, L; Maestro, R; Santarosa, M; Tonin, E; Viel, A | 1 |
| Deutsch, E; Loriot, Y; Mordant, P; Olaussen, KA; Soria, JC | 1 |
| Darroudi, F; de Groot, J; de Winter, JP; Godthelp, BC; Joenje, H; Oostra, AB; Scheper, RJ; Steltenpool, J; van der Lelij, P; van Gosliga, D; van Zon, W; Waisfisz, Q; Wolthuis, RM | 1 |
| Kepp, O; Kroemer, G; Martins, I; Métivier, D; Michaud, M; Perfettini, JL; Schlemmer, F; Senovilla, L; Séror, C; Tesniere, A; Zitvogel, L | 1 |
| Bazin, IS; Fedyanin, MY; Garin, AM; Kanagavel, D; Narimanov, MN; Pokataev, IA; Tjulandin, SA; Tryakin, AA; Yakovleva, ES | 1 |
| Fowler, P; Jeffrey, L; Kirkland, D; Smith, K; Whitwell, J; Young, J | 1 |
| Elhajouji, A | 1 |
| Bushell, M; Chew, EH; Chua, YL; Gao, J; Hagen, T; Lou, JJ | 1 |
| Hiroshima, K; Kawamura, K; Kobayashi, H; Li, Q; Liang, M; Ma, G; Okamoto, S; Shimada, H; Suzuki, N; Tada, Y; Tagawa, M; Tatsumi, K | 1 |
| Aldabbagh, K; Fabbro, M; Jacot, W; Pouderoux, S; Poujol, S; Roca, L; Romieu, G | 1 |
| Berghella, L; Cossu, G; Innocenzi, A; Latella, L; Marullo, F; Messina, G; Poizat, C; Puri, PL; Shu, CW; Simonatto, M; Wang, JY | 1 |
| Chan, M; Chen, H; DeVito, GL; Murli, H; Roberts, DJ; Sanok, K; Spellman, RA; Stankowski, LF; Thakur, AK; Yurt, P | 1 |
| Boisvert, RA; Cavallo, F; Esashi, F; Howlett, NG; Jasin, M; Mauro, M; Rego, MA | 1 |
| Köhler, R; Krammer, PH; Li-Weber, M; Lüpertz, R; Merz, C; Müller, WW; Natoli, A | 1 |
| Dobo, KL; Schuler, M; Sobol, Z; Spellman, RA; Thiffeault, C | 1 |
| Bar-Sela, G; Miller, RC; Novotny, PJ; Sio, TT; Sohawon, S; Thariat, J; Van Houtte, P; Vu, CC | 1 |
| Carvalho, MA; Carvalho, RS; Chammas, R; Fernandes, VC; Monteiro, AN; Nepomuceno, TC; Rodrigues, DC; Suarez-Kurtz, G; Woods, NT | 1 |
| Harada, A; Matsuzaki, K; Mishima, M; Takeiri, A | 1 |
| Huang, XE; Ji, ZQ; Liu, J; Tang, JH; Wang, L; Wu, XY | 1 |
| Chua, CW; Gelmann, EP; Shen, M; Zhang, H; Zheng, T | 1 |
19 review(s) available for etoposide and mitomycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Cascade synthetic strategies opening access to medicinal-relevant aliphatic 3- and 4-membered N-heterocyclic scaffolds.
Topics: Bridged Bicyclo Compounds; Nitrogen | 2022 |
Cytotoxic treatment of metastatic breast cancer. Which drugs and drug combinations to use?
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Mitomycin; Mitoxantrone; Neoplasm Metastasis; Vincristine | 1992 |
[Dose intensity chemotherapy in lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Mitomycin; Mitomycins; Progesterone; Recombinant Proteins; Remission Induction; Vinblastine; Vincristine | 1990 |
Second generation analogs of etoposide and mitomycin C.
Topics: Animals; Antineoplastic Agents; Dogs; Drug Screening Assays, Antitumor; Etoposide; Humans; Mice; Mitomycin; Mitomycins; Organophosphorus Compounds | 1990 |
Current chemotherapy of small cell lung cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Complement Membrane Attack Complex; Complement System Proteins; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Lomustine; Lung Neoplasms; Methotrexate; Mitomycin; Mitomycins; Podophyllotoxin; Procarbazine; Prognosis; Time Factors; Vincristine | 1986 |
Chemotherapy of non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Tolerance; Etoposide; Humans; Lung Neoplasms; Mitomycin; Mitomycins; Vindesine | 1985 |
Chemotherapy of esophageal cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Esophageal Neoplasms; Etoposide; Fluorouracil; Humans; Lomustine; Methotrexate; Mitoguazone; Mitomycin; Mitomycins; Neoplasm Metastasis; Postoperative Care; Preoperative Care; Vinblastine; Vindesine | 1984 |
[Chemotherapy of scirrhous gastric cancer].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Fluorouracil; Humans; Interferon alpha-2; Interferon-alpha; Leucovorin; Levoleucovorin; Mitomycin; Nimustine; Recombinant Proteins; Stomach Neoplasms; Tegafur; Uracil | 1994 |
The cost-effectiveness of four cisplatin-containing chemotherapy regimens in the treatment of stages III B and IV non-small cell lung cancer: an Italian perspective.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cost-Benefit Analysis; Deoxycytidine; Etoposide; Gemcitabine; Health Care Costs; Humans; Ifosfamide; Insurance, Health, Reimbursement; Italy; Lung Neoplasms; Mitomycin; Ribonucleotide Reductases; Vinblastine; Vinorelbine | 1996 |
Combination chemotherapy studies with gemcitabine.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cisplatin; Deoxycytidine; Drug Synergism; Etoposide; Gemcitabine; Humans; Mitomycin; Neoplasms; Ribonucleotide Reductases; Tumor Cells, Cultured | 1997 |
[Adjuvant chemotherapy of lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Lung Neoplasms; Mitomycin; Neoplasm Recurrence, Local; Vincristine | 1987 |
[Treatment of recurrent gastric cancer].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Fluorouracil; Humans; Immunologic Factors; Irinotecan; Liver Neoplasms; Lymphatic Metastasis; Methotrexate; Mitomycin; Neoplastic Cells, Circulating; Peritoneal Neoplasms; Stomach Neoplasms | 1998 |
Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Lymphatic Metastasis; Male; Mesna; Methotrexate; Middle Aged; Mitomycin; Nasal Cavity; Nose Neoplasms; Paranasal Sinus Neoplasms; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 1998 |
[Combination chemotherapy--present status and problems].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Fluorouracil; Humans; Infusions, Intravenous; Injections, Intravenous; Mitomycin; Neoplasms | 1999 |
Preoperative therapy for local-regional gastric cancer: rationale and review of trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Doxorubicin; Etoposide; Fluorouracil; Humans; Methotrexate; Mitomycin; Preoperative Care; Stomach Neoplasms; Tegafur; Uracil | 2000 |
[Chemotherapy with mitomycin C, etoposide and cisplatin for adenocarcinoma of the uterine cervix].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Humans; Mitomycin; Neoadjuvant Therapy; Prognosis; Uterine Cervical Neoplasms | 2004 |
Pseudomyxoma peritonei accompanied by intraductal papillary mucinous neoplasm of the pancreas.
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Ascites; Carcinoma, Pancreatic Ductal; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Deoxycytidine; Etoposide; Gemcitabine; Humans; Hyperthermia, Induced; Infusions, Parenteral; Male; Middle Aged; Mitomycin; Neoplasms, Multiple Primary; Pancreatic Neoplasms; Peritoneal Neoplasms; Pseudomyxoma Peritonei | 2005 |
Are RAS mutations predictive markers of resistance to standard chemotherapy?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase III as Topic; Clinical Trials, Phase IV as Topic; Colorectal Neoplasms; Combined Modality Therapy; Drug Resistance, Neoplasm; Drug Therapy; Etoposide; Genes, ras; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mutation; Predictive Value of Tests; Prognosis; Survival Analysis; Treatment Outcome | 2009 |
43 trial(s) available for etoposide and mitomycin
| Article | Year |
|---|---|
Results of adjuvant chemotherapy for invasive uroepithelial cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Kidney Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Survival Rate; Ureteral Neoplasms; Urinary Bladder Neoplasms | 1992 |
Cisplatin plus VP-16 combination chemotherapy in advanced refractory breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Drug Synergism; Etoposide; Female; Fluorouracil; Humans; Lung Neoplasms; Lymphatic Metastasis; Methotrexate; Middle Aged; Mitomycin; Skin Neoplasms; Time Factors | 1992 |
A randomized trial with mitomycin-C/ifosfamide versus mitomycin-C/vindesine versus cisplatin/etoposide in advanced non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Survival Rate; Vindesine | 1991 |
[Prognostic factors affecting survival and response in patients with advanced non-small cell lung cancer treated with combination chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Multivariate Analysis; Prognosis; Proportional Hazards Models; Prospective Studies; Randomized Controlled Trials as Topic; Regression Analysis; Remission Induction; Sex Factors; Survival Rate; Vindesine | 1990 |
A randomized trial fo three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Organoplatinum Compounds; Prognosis; Prospective Studies; Remission Induction; Survival Analysis | 1990 |
[Current results of chemotherapy in non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Prognosis; Survival Rate; Vindesine | 1990 |
[Chemotherapy of advanced non-small cell bronchial cancer with mitomycin C/ifosfamide versus mitomycin C/vindesine versus cisplatin/etoposide--a prospective randomized study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Mitomycin; Mitomycins; Prospective Studies; Randomized Controlled Trials as Topic; Vindesine | 1990 |
[Effect of PMUE therapy (CDDP, MMC, UFT, etoposide) in terminal gastric cancer].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Gastrectomy; Humans; Injections, Intravenous; Japan; Male; Middle Aged; Mitomycin; Mitomycins; Remission Induction; Stomach Neoplasms; Survival Rate; Tegafur; Terminal Care; Uracil | 1990 |
A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Prognosis; Random Allocation; Remission Induction; Warfarin | 1989 |
Treatment of advanced non-small cell lung cancer (NSCLC): the "Umbria" cooperative study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Random Allocation | 1988 |
[Restorative effect of muroctasin, MDP-Lys (L 18), on leukopenia caused by anticancer chemotherapy in lung cancer--comparative study by envelope method].
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Random Allocation; Vincristine; Vindesine | 1988 |
A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Procarbazine; Progesterone; Random Allocation; Vinblastine; Vindesine | 1986 |
Mitomycin-C, etoposide, cisplatin, and hexamethylmelamine (MEPH) as a second-line regimen in lung cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Thrombocytopenia; Vomiting | 1984 |
Preoperative chemotherapy and immunochemotherapy for locally advanced stage IIIA and IIIB non small cell lung cancer. Preliminary results.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Interferons; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Neoplasm Staging; Pneumonectomy; Remission Induction; Survival Rate; Vinblastine | 1995 |
Superiority of three-drug combination chemotherapy versus cisplatin-etoposide in advanced non-small cell lung cancer: a randomized trial by the Italian Oncology Group for Clinical Research.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mitomycin; Survival Rate; Treatment Outcome; Vindesine | 1995 |
Chemotherapy of advanced non-small-cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Italy; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Neoplasm Staging; Retrospective Studies; Survival Rate; Vindesine | 1995 |
Salvage chemotherapy with PEM and long-CF regimen in CDDP refractory advanced head and neck cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Leukopenia; Male; Middle Aged; Mitomycin; Nausea; Salvage Therapy; Vomiting | 1995 |
[Effect of intraperitoneal chemotherapy with implantable reservoir against unresectable gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Infusions, Parenteral; Male; Middle Aged; Mitomycin; Stomach Neoplasms | 1995 |
[The effect of intraperitoneal and intra-aortic chemotherapy for unresectable gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Infusions, Parenteral; Male; Middle Aged; Mitomycin; Prognosis; Stomach Neoplasms | 1994 |
A randomized clinical trial in bronchogenic small-cell carcinoma evaluating alternating maintenance therapy of vincristine, adriamycin, procarbazine, and etoposide (VAPE) with cyclophosphamide, CCNU, and methotrexate (CCM) versus CCM maintenance alone in
Topics: Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Procarbazine; Remission Induction; Vinblastine; Vincristine | 1994 |
Mitomycin C etoposide and vinorelbine (MEV II) in the treatment of metastatic stage IV non small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Survival Analysis; Treatment Outcome; Vinblastine; Vinorelbine | 1994 |
[Evaluation of combination chemotherapy for advanced gastric carcinoma as a neoadjuvant chemotherapy with CDDP, MMC, etoposide and 5'-DFUR].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Female; Floxuridine; Humans; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Stomach Neoplasms | 1994 |
Treatment of advanced non-small cell lung cancer with very high-dose cisplatin combined with etoposide and mitomycin C.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin | 1993 |
Chemotherapy in gastric cancer: an economic evaluation of the FAM (5-fluorouracil, adriamycin, mitomycin C) versus ELF (etoposide, leucovorin, 5-fluorouracil) regimens.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cost-Benefit Analysis; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Levoleucovorin; Male; Middle Aged; Mitomycin; Stomach Neoplasms | 1995 |
[Clinical effect of intra-arterial carboplatin-combined chemotherapy for advanced uterine cervical cancer and increased tissue platinum levels with Lipo PGE1 administration before chemotherapy].
Topics: Adenocarcinoma; Adult; Aged; Alprostadil; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cervix Uteri; Chemotherapy, Adjuvant; Epirubicin; Etoposide; Female; Humans; Iliac Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Middle Aged; Mitomycin; Platinum; Uterine Cervical Neoplasms; Vindesine | 1996 |
Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. The "Gruppo Oncologico Centro-Sud-Isole' (G.O.C.S.I.).
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Mitomycin; Multivariate Analysis; Survival Rate; Treatment Outcome; Vindesine | 1996 |
A phase II study of mitomycin C and oral etoposide for advanced adenocarcinoma of the upper gastrointestinal tract.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Esophageal Neoplasms; Etoposide; Female; Humans; Injections, Intravenous; Male; Middle Aged; Mitomycin; Stomach Neoplasms; Treatment Outcome | 1997 |
[A study on treatment of lung cancer by combined therapy of traditional Chinese medicine and chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Diagnosis, Differential; Drugs, Chinese Herbal; Etoposide; Female; Humans; Lung Neoplasms; Male; Medicine, Chinese Traditional; Middle Aged; Mitomycin; Survival Rate; Vindesine | 1996 |
Advanced non-small cell lung cancer chemotherapy: a randomized trial of two active regimens (MVP and PE).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Double-Blind Method; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Treatment Outcome; Vindesine | 1997 |
Results of a phase II trial of combined chemotherapy for patients with diffuse malignant mesothelioma of the pleura.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asbestos; Cisplatin; Combined Modality Therapy; Etoposide; Female; Filgrastim; Fluorouracil; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Immunotherapy; Leucovorin; Male; Mesothelioma; Middle Aged; Mitomycin; Pleural Neoplasms; Prospective Studies; Recombinant Proteins; Remission Induction; Survival Analysis; Treatment Outcome | 1999 |
Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: evaluation by multivariate regression analysis.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Etoposide; Female; Hot Temperature; Humans; Male; Middle Aged; Mitomycin; Multivariate Analysis; Peritoneal Cavity; Peritoneal Neoplasms; Proportional Hazards Models; Stomach Neoplasms; Treatment Outcome | 1999 |
[Arterial infusion therapy with implantable port for inoperable hepatobiliary tumors].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Cisplatin; Colonic Neoplasms; Drug Administration Schedule; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Stomach Neoplasms | 1999 |
Three new active cisplatin-containing combinations in the neoadjuvant treatment of locally advanced and locally recurrent breast carcinoma: a randomized phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Epirubicin; Etoposide; Female; Humans; Leucovorin; Methotrexate; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Vincristine | 1999 |
A phase II study of mitomycin C, etoposide, and cisplatin in advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Survival Analysis; Time Factors | 2000 |
Survival results of neoadjuvant chemotherapy for advanced squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mitomycin; Neoadjuvant Therapy; Survival Analysis | 2000 |
Effect of chemotherapy on pulmonary epithelial permeability in lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Gas Analysis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Membrane Permeability; Cisplatin; Doxorubicin; Etoposide; Forced Expiratory Volume; Humans; Ifosfamide; Lung; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Mitomycin; Mucociliary Clearance; Respiratory Mucosa; Technetium Tc 99m Pentetate; Vital Capacity | 2000 |
The relationship between improved prognosis in gastric cancer patients in the last 25 years and changing methods of surgical and combined treatment.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Gastrectomy; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Staging; Pilot Projects; Prognosis; Prospective Studies; Stomach Neoplasms; Survival Rate | 2000 |
[Twenty-year experience with multimodal treatment of gastric cancer patients in Poland].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Fluorouracil; Gastrectomy; Humans; Immunotherapy; Lymph Node Excision; Male; Middle Aged; Mitomycin; Palliative Care; Poland; Prognosis; Prospective Studies; Regression Analysis; Stomach Neoplasms; Survival Analysis; Time Factors; Treatment Outcome | 2001 |
[Effectiveness of continuous hyperthermic peritoneal perfusion for the peritoneal dissemination of gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Etoposide; Female; Humans; Hyperthermia, Induced; Male; Middle Aged; Mitomycin; Peritoneal Neoplasms; Prognosis; Regression Analysis; Stomach Neoplasms | 2002 |
[Influence of combined therapy of guben yiliu III, moxibustion and chemotherapy on immune function and blood coagulation mechanism in patients with mid-late stage malignant tumor].
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Drugs, Chinese Herbal; Etoposide; Female; Fluorouracil; Humans; Lung Neoplasms; Lymphocyte Count; Male; Mitomycin; Moxibustion; Phytotherapy; Stomach Neoplasms; T-Lymphocyte Subsets | 2002 |
[Clinical study on effect of Astragalus in efficacy enhancing and toxicity reducing of chemotherapy in patients of malignant tumor].
Topics: Antineoplastic Combined Chemotherapy Protocols; Astragalus propinquus; CD4-CD8 Ratio; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Drugs, Chinese Herbal; Etoposide; Female; Fluorouracil; Humans; Immunoglobulin G; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Mitomycin; Phytotherapy; Stomach Neoplasms | 2002 |
Mitomycin C and etoposide in advanced colorectal carcinoma. A clinical and in vitro experience that focuses the problem of schedule dependence in combination therapy.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma; Cell Cycle; Cell Line, Tumor; Colorectal Neoplasms; Etoposide; Female; Humans; Male; Middle Aged; Mitomycin | 2007 |
A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Docetaxel; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taxoids | 2010 |
183 other study(ies) available for etoposide and mitomycin
| Article | Year |
|---|---|
Structure-activity relationships of antineoplastic agents in multidrug resistance.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Cell-based screen for identification of inhibitors of tubulin polymerization.
Topics: Animals; Brain Neoplasms; Bucladesine; Cell Differentiation; Drug Screening Assays, Antitumor; Formazans; Glioma; Rats; Tubulin; Tumor Cells, Cultured | 1996 |
Synthesis and antitumour activity of novel diterpenequinone salvicine and the analogs.
Topics: Animals; Antineoplastic Agents, Phytogenic; Drug Screening Assays, Antitumor; Humans; Magnetic Resonance Spectroscopy; Mice; Molecular Structure; Naphthoquinones; Tumor Cells, Cultured | 1999 |
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Analysis of the four combination chemotherapies in non-small cell lung cancer treated at Maharaj Nakorn Chiang Mai Hospital.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Mitomycin; Survival Rate; Vinblastine | 1992 |
Potentiation of topoisomerase I and II inhibitors cell killing by tumor necrosis factor: relationship to DNA strand breakage formation.
Topics: Camptothecin; Cell Death; Cisplatin; DNA Damage; DNA, Neoplasm; Drug Synergism; Epirubicin; Etoposide; Female; Humans; Mitomycin; Ovarian Neoplasms; Recombinant Proteins; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1992 |
Chemotherapy for gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Fluorouracil; Humans; Middle Aged; Mitomycin; Prognosis; Stomach Neoplasms | 1992 |
[PMUE therapy (CDDP, MMC, UFT, etoposide) for advanced gastric cancer--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Gastrectomy; Humans; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Remission Induction; Reoperation; Stomach Neoplasms; Tegafur; Uracil | 1992 |
[A case of gastric cancer with multiple liver metastases effectively treated with PMUE (CDDP, MMC, UFT, etoposide) hepatic arterial chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Gastrectomy; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Prognosis; Stomach Neoplasms; Tegafur; Uracil | 1992 |
The succinate dehydrogenase inhibition test for evaluating biopsy specimens and resected tumors of advanced gastric cancer.
Topics: Aged; Biopsy; Cisplatin; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Mitomycin; Stomach Neoplasms; Succinate Dehydrogenase | 1992 |
[Characterization of two novel cell lines established from a single human uterine cervical adenocarcinoma, and their chemosensitivities and hormonal effects on their proliferation].
Topics: Adenocarcinoma; Animals; Carbazilquinone; Cell Division; Drug Screening Assays, Antitumor; Estradiol; Etoposide; Female; Humans; Methotrexate; Mice; Mitomycin; Neoplasm Transplantation; Progesterone; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1992 |
[A resected case of advanced gastric cancer with complete remission of liver metastasis by chronic daily administration of oral etoposide and UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Etoposide; Gastrectomy; Humans; Liver Neoplasms; Lymph Node Excision; Male; Mitomycin; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1992 |
[Intra-arterial infusion chemotherapy for unresectable hepatocellular carcinoma using an implantable reservoir].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Etoposide; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Mitomycin; Mitomycins | 1991 |
[Clinical evaluation of intra-arterial infusion of hyperthermo-chemotherapy in gastric cancer].
Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Etoposide; Fluorouracil; Humans; Hyperthermia, Induced; Infusion Pumps; Infusions, Intra-Arterial; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Mitomycins; Stomach Neoplasms | 1991 |
Phase II study of mitomycin C, etoposide and vindesine in metastatic stage IV non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Etoposide; Humans; Lung Neoplasms; Lymphatic Metastasis; Mitomycin; Neoplasm Staging; Remission Induction; Time Factors; Vindesine | 1991 |
[The modification of the toxicity produced by chemotherapy in testicular cancer by adapting its intensity to prognostic groups].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Iatrogenic Disease; Ifosfamide; Male; Mitomycin; Prognosis; Testicular Neoplasms; Vinblastine; Vincristine | 1991 |
[5'-deoxy-5-fluorouridine (5'-DFUR), mitomycin C (MMC), etoposide and medroxy progesterone acetate (MPA) in a previously treated patient with advanced breast cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Etoposide; Female; Floxuridine; Humans; Liver Neoplasms; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Mitomycin; Mitomycins; Remission Induction | 1991 |
[In vitro chemosensitivity test using collagen gel matrix for human gastric carcinomas].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Agents; Cisplatin; Collagen; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Gels; Humans; Mitomycin; Mitomycins; Stomach Neoplasms; Tumor Cells, Cultured | 1991 |
[In vivo assessment on the therapeutic effects of etoposide, vincristine and mitomycin C against human neuroblastoma].
Topics: Animals; Child, Preschool; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Infant; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Mitomycins; Neoplasm Transplantation; Neuroblastoma; Vincristine | 1991 |
[Chemosensitivity test for gastric cancer by in vitro MTT assay].
Topics: Antineoplastic Agents; Carbazilquinone; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Fluorouracil; Humans; Mitomycin; Mitomycins; Stomach Neoplasms; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1991 |
[Intraperitoneal administration of cis-platin with arterial infusion chemotherapy of advanced and recurrent gastric cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Infusions, Parenteral; Male; Middle Aged; Mitomycin; Mitomycins; Picibanil; Stomach Neoplasms | 1991 |
[CDDP-ip PMUE therapy in gastric cancer cases with liver metastasis].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Gastrectomy; Humans; Infusions, Parenteral; Injections, Intravenous; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Mitomycins; Peritonitis; Stomach Neoplasms; Tegafur; Uracil | 1991 |
[Combination chemotherapy of HO-221, a derivative of benzoylphenylurea with various anticancer agents against human cancer xenografts in nude mice].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cell Division; Cisplatin; Doxorubicin; Drug Synergism; Etoposide; Humans; Mice; Mice, Nude; Mitomycin; Neoplasm Transplantation; Nitrobenzenes; Pancreatic Neoplasms; Stomach Neoplasms | 1991 |
[Prophylactic effect of allopurinol mouthwash against stomatitis induced by the chemotherapy (PMUE regimen) for gastrointestinal malignancies].
Topics: Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Gastrointestinal Neoplasms; Humans; Male; Mitomycin; Mouthwashes; Stomatitis; Tegafur; Uracil | 1991 |
[Neoadjuvant chemotherapy of far advanced gastric cancer--effect of preoperative chemotherapy by PMUE (CDDP, MMC, UFT, etoposide].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Preoperative Care; Prognosis; Stomach Neoplasms; Tegafur; Uracil | 1990 |
[In vitro combined effects of pirarubicin (THP) and various antitumor drugs on human tumor cell lines].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Humans; Leukemia, Myeloid; Methotrexate; Mitomycin; Mitomycins; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1990 |
[Effect of etoposide orally administered every other day for the prevention of recurrence of bladder tumor].
Topics: Administration, Intravesical; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Postoperative Period; Urinary Bladder Neoplasms | 1990 |
[A study of combined chemotherapy with MMC, ADM, CDDP, etoposide (VP-16), 5'DFUR (MAC-VD therapy) in advanced cancer and local relapse of the stomach].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Floxuridine; Humans; Infusions, Intravenous; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Stomach Neoplasms | 1990 |
[The changes in tumor markers such as serum CEA, CA 19-9, TPA and CA 125 in the chemotherapy of patients with advanced gastric cancer].
Topics: Adolescent; Adult; Aged; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoembryonic Antigen; Cisplatin; Doxorubicin; Etoposide; Female; Floxuridine; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Peptides; Remission Induction; Stomach Neoplasms; Tissue Polypeptide Antigen | 1990 |
[Study on endoscopic features in responders to systemic chemotherapy in advanced gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Floxuridine; Gastroscopy; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Remission Induction; Stomach Neoplasms | 1990 |
[Intra-hepato-arterial infusion chemotherapy using catheter inserted and placed in hepatic artery via the left radial artery on liver malignancy].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheterization; Cisplatin; Colonic Neoplasms; Embolization, Therapeutic; Etoposide; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Stomach Neoplasms | 1990 |
[Current perspectives in the management of non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Drug Evaluation; Etoposide; Fluorouracil; Humans; Lung Neoplasms; Mitomycin; Mitomycins; Vinblastine; Vincristine; Vindesine | 1985 |
Antibacterial activities of antineoplastic agents.
Topics: Antineoplastic Agents; Bacteria; Bleomycin; Doxorubicin; Etoposide; Fluorouracil; Methotrexate; Microbial Sensitivity Tests; Mitomycin; Mitomycins | 1985 |
Differential protective effects of varying degrees of hypoxia on the cytotoxicities of etoposide and bleomycin.
Topics: Bleomycin; Cell Line; Cell Survival; Doxorubicin; Drug Resistance; Etoposide; Humans; Mitomycin; Mitomycins; Mitotic Index; Oxygen; Sarcoma | 1987 |
Etoposide and mitomycin-C in pretreated metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis | 1989 |
[A study of combined chemotherapy with MMC, ADM, CDDP, VP-16 and 5'DFUR (MAC-VD) in advanced cancers of digestive organs].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Floxuridine; Gallbladder Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Mitomycin; Mitomycins; Splenic Neoplasms; Stomach Neoplasms | 1989 |
Cytotoxicity mediated by tumor necrosis factor in variant subclones of the ME-180 cervical carcinoma line: modulation by specific inhibitors of DNA topoisomerase II.
Topics: Cell Communication; Cell Survival; DNA Topoisomerases, Type II; Drug Synergism; Etoposide; Female; Kinetics; Lymphotoxin-alpha; Mitomycin; Mitomycins; Teniposide; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Uterine Cervical Neoplasms | 1989 |
Systemic therapy for small-cell lung cancer: old themes replayed, new ones awaited.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lomustine; Lung Neoplasms; Methotrexate; Mitomycin; Mitomycins | 1989 |
Serial measurement of sister chromatid exchanges in the peripheral lymphocytes of patients with lung cancer receiving chemotherapy in relation to bone marrow toxicity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lung Neoplasms; Lymphocytes; Mitomycin; Mitomycins; Sister Chromatid Exchange; Vincristine; Vindesine | 1989 |
Sister chromatid exchanges, chromosomal aberrations, and cytotoxicity produced by antitumor topoisomerase II inhibitors in sensitive (DC3F) and resistant (DC3F/9-OHE) Chinese hamster cells.
Topics: Amsacrine; Animals; Camptothecin; Cell Line; Cell Survival; Chromosome Aberrations; Cricetinae; Drug Resistance; Ellipticines; Etoposide; Mitomycin; Mitomycins; Sister Chromatid Exchange; Topoisomerase II Inhibitors | 1988 |
Neurologic dysfunction in patients treated for small cell carcinoma of the lung: a clinical and radiological study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Diseases; Brain Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Procarbazine; Vincristine | 1986 |
[Combination chemotherapy with etoposide, mitomycin C, and cyclophosphamide in advanced non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Mitomycins | 1986 |
[Treatment of non-small cell cancer of the lung with a combination of cisplatin-VP-16 and mitomycin C].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins | 1987 |
[A case report of an advanced ovarian cancer (stage T4) treated with a total amount of 1815 mg of CDDP].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Mitomycin; Mitomycins; Ovarian Neoplasms | 1987 |
The search for more active and less toxic mitomycin and etoposide analogs.
Topics: Animals; Antineoplastic Agents; Etoposide; Mice; Mitomycin; Mitomycins | 1987 |
Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study.
Topics: Adenocarcinoma; Aged; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Procarbazine; Progesterone; Prognosis; Serum Albumin; Vinblastine | 1986 |
Suppression of natural killer activity in patients treated with cisplatin and methylprednisolone.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytotoxicity Tests, Immunologic; Doxorubicin; Etoposide; Female; Humans; Immune Tolerance; In Vitro Techniques; Killer Cells, Natural; Lung Neoplasms; Male; Mediastinal Neoplasms; Methylprednisolone; Middle Aged; Mitomycin; Mitomycins; Nimustine; Nitrosourea Compounds; Vinblastine; Vindesine | 1985 |
Combination of mitomycin C + etoposide in advanced gastric carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Stomach Neoplasms | 1985 |
[Chemosensitivity in established human bladder carcinoma and HELA cell lines in vitro].
Topics: Antineoplastic Agents; Bleomycin; Carbazilquinone; Carcinoma, Transitional Cell; Cell Division; Cell Line; Cell Survival; Cells, Cultured; Cisplatin; Doxorubicin; Drug Evaluation, Preclinical; Etoposide; HeLa Cells; Humans; Male; Mitomycin; Mitomycins; Nimustine; Nitrosourea Compounds; Thiotepa; Urinary Bladder Neoplasms | 1983 |
[Multidisciplinary treatment for small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Nimustine; Nitrosourea Compounds; Vincristine | 1984 |
Mitomycin-C, VP16-213 combination as third line chemotherapy in advanced breast cancer.
Topics: Adult; Breast Neoplasms; Drug Therapy, Combination; Etoposide; Female; Humans; Middle Aged; Mitomycin; Mitomycins; Podophyllotoxin | 1982 |
[A case of gastric cancer responding well to MTX/5-FU (methotrexate/5-fluorouracil) and PMUE (CDDP, MMC, UFT, etoposide) therapies upon lymphnode recurrence].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Mitomycin; Stomach Neoplasms; Tegafur; Uracil | 1995 |
Sister-chromatid exchanges, chromosomal aberrations and cytotoxicity produced by topoisomerase II-targeted drugs in sensitive (A2780) and resistant (A2780-DX3) human ovarian cancer cells: correlations with the formation of DNA double-strand breaks.
Topics: Antineoplastic Agents; Cell Survival; Chromosome Aberrations; DNA Damage; DNA, Neoplasm; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Humans; Mitomycin; Ovarian Neoplasms; Sister Chromatid Exchange; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1994 |
[Experimental and clinical study on chemotherapy for cervical adenocarcinoma].
Topics: Aclarubicin; Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mitomycin; Neoplasm Transplantation; Uterine Cervical Neoplasms | 1995 |
A novel type of X-ray-sensitive Chinese hamster cell mutant with radioresistant DNA synthesis and hampered DNA double-strand break repair.
Topics: Animals; Bleomycin; Cell Survival; CHO Cells; Cricetinae; DNA; DNA Damage; DNA Repair; DNA Replication; Enzyme Inhibitors; Etoposide; Free Radicals; Gamma Rays; Genetic Complementation Test; Mitomycin; Mutagens; Radiation, Ionizing; Streptonigrin; Topoisomerase I Inhibitors; X-Rays | 1995 |
Characterization of carboplatin-resistant sublines derived from human larynx carcinoma cells.
Topics: Antineoplastic Agents; Carboplatin; Cell Survival; Cisplatin; Clone Cells; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fluorouracil; Glutathione; Glutathione Transferase; Humans; Laryngeal Neoplasms; Mitomycin; Proto-Oncogenes; Tumor Cells, Cultured; Vinblastine; Vincristine | 1995 |
[Chemohyperthermic peritoneal perfusion and subtotal peritonectomy for peritonitis carcinomatosa in gastroenteric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Combined Modality Therapy; Etoposide; Female; Humans; Hyperthermia, Induced; Male; Middle Aged; Mitomycin; Neoplasm Invasiveness; Perfusion; Peritoneal Lavage; Peritoneal Neoplasms; Peritoneum; Peritonitis; Stomach Neoplasms | 1995 |
Chemotherapy of human small-cell gastrointestinal carcinoma xenografts in nude mice.
Topics: Aged; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Esophageal Neoplasms; Etoposide; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mitomycin; Neoplasm Transplantation; Phosphopyruvate Hydratase; Remission Induction; Stomach Neoplasms; Transplantation, Heterologous | 1995 |
Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide.
Topics: Antineoplastic Agents; Cisplatin; DNA; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Etoposide; Humans; Mitomycin; Thioredoxins; Tumor Cells, Cultured | 1995 |
Induction chemotherapy with cisplatin, etoposide, and mitomycin-C (PEM) regimen in advanced cases with cancer of pharynx and oral cavity.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Mitomycin; Mouth Neoplasms; Neoplasm Staging; Pharyngeal Neoplasms; Remission Induction | 1995 |
The effect of anticancer drug sequence in experimental combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Survival; Cisplatin; Drug Administration Schedule; Endometrial Neoplasms; Etoposide; Female; Humans; Kinetics; Mitomycin; Multiple Myeloma; Tumor Cells, Cultured | 1993 |
Effects of mitomycin-C and etoposide in cell culture and in nude mice: the role of G-CSF mutein.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Laryngeal Neoplasms; Mice; Mice, Nude; Mitomycin; Tumor Cells, Cultured | 1993 |
Apoptosis and nuclear levels of p53 protein and proliferating cell nuclear antigen in human hepatoma cells cultured with tumor promoters.
Topics: Apoptosis; Carcinogens; Carcinoma, Hepatocellular; DNA Damage; Etoposide; Flow Cytometry; Humans; Lyngbya Toxins; Mitomycin; Proliferating Cell Nuclear Antigen; Terpenes; Thapsigargin; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1995 |
The influence of ageing on cisplatin pharmacokinetics in lung cancer patients with normal organ function.
Topics: Adult; Aged; Aged, 80 and over; Aging; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Regression Analysis; Vindesine | 1995 |
Effects of single and combined application of anti-cancer drugs on cervical adenocarcinoma. I. Antitumor activity in vitro.
Topics: Adenocarcinoma; Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Combined Modality Therapy; Etoposide; Female; Humans; In Vitro Techniques; Interferon-gamma; Mice; Mice, Nude; Middle Aged; Mitomycin; Neoplasms, Experimental; Recombinant Proteins; Uterine Cervical Neoplasms | 1995 |
Human larynx carcinoma cells resistant to cis-diamminedichloroplatinum(II): cross-resistance patterns.
Topics: Antineoplastic Agents; Cisplatin; Drug Resistance; Drug Screening Assays, Antitumor; Etoposide; Humans; Laryngeal Neoplasms; Mitomycin; Tumor Cells, Cultured | 1994 |
[A case of cutaneous and brain metastasis of gastric carcinoma, treated effectively by chemotherapy with CDDP, MMC, etoposide and 5'-DFUR].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Drug Administration Schedule; Etoposide; Female; Floxuridine; Humans; Infusions, Intravenous; Mitomycin; Neoplasm Invasiveness; Skin Neoplasms; Stomach Neoplasms; Treatment Outcome | 1994 |
Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Colonic Neoplasms; Cyclophosphamide; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Ifosfamide; Leukemia P388; Mammary Neoplasms, Animal; Melanoma, Experimental; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mitomycin; Sarcoma, Experimental; Vinblastine | 1994 |
Analysis of micronuclei induced in mouse early spermatids by mitomycin C, vinblastine sulfate or etoposide using fluorescence in situ hybridization.
Topics: Animals; Autoimmune Diseases; Centromere; CREST Syndrome; DNA Probes; Etoposide; Fluorescent Antibody Technique; In Situ Hybridization, Fluorescence; Male; Mice; Micronucleus Tests; Mitomycin; Spermatids; Spindle Apparatus; Topoisomerase II Inhibitors; Vinblastine | 1993 |
[Intraarterial infusion chemotherapy for recurrent or unresectable gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Mitomycin; Peritonitis; Prognosis; Stomach Neoplasms; Survival Rate | 1993 |
[A new cell line derived from a nude mouse resembling human large cell lung cancer].
Topics: Adult; Animals; Carcinoma, Non-Small-Cell Lung; Cisplatin; Doxorubicin; Etoposide; Fluorouracil; Genes, myc; Genes, ras; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Mitomycin; Neoplasm Transplantation; Subrenal Capsule Assay; Tumor Cells, Cultured | 1993 |
[A case of gastric cancer with multiple liver metastases showing marked efficacy of preoperative and postoperative chemotherapy with CDDP, MMC and UFT(PMU), or CDDP, MMC, UFT and etoposide (PMUE)].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Hepatectomy; Hepatic Artery; Humans; Infusion Pumps; Liver Neoplasms; Lymphatic Metastasis; Male; Mitomycin; Postoperative Care; Preoperative Care; Stomach Neoplasms; Tegafur; Uracil | 1993 |
Antitumor activity of treosulfan in human lung carcinomas.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Busulfan; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Male; Mice; Mice, Nude; Mitomycin; Neoplasm Transplantation; Time Factors | 1996 |
Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Carcinoma, Transitional Cell; Cisplatin; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Fluorouracil; Humans; Mitomycin; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Selection, Genetic; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Verapamil; Vinca Alkaloids | 1995 |
Investigation of the comparative effects of 2-chlorodeoxyadenosine on tumor colony forming units in vitro.
Topics: Antineoplastic Agents; Cell Division; Cisplatin; Cladribine; Dose-Response Relationship, Drug; Doxorubicin; Drugs, Investigational; Etoposide; Fluorouracil; Humans; Mitomycin; Neoplasms; Neoplastic Stem Cells; Tumor Stem Cell Assay; Vinblastine | 1995 |
[Combined chemotherapy with MMC, ADM, CDDP, etoposide (VP-16) and 5'-DFUR, (MACVD therapy) as a second-line chemotherapy for metastatic gastric cancer: three cases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Floxuridine; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Stomach Neoplasms | 1996 |
[The results of chemosensitivity test for clear cell adenocarcinoma of the ovary].
Topics: Adenocarcinoma, Clear Cell; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Irinotecan; Mitomycin; Ovarian Neoplasms | 1996 |
[Efficacy of the chemosensitivity test using collagen gel matrix-supported culture system for urogenital tumors].
Topics: Animals; Antineoplastic Agents; Bleomycin; Carcinoma, Renal Cell; Cisplatin; Collagen; Culture Media; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Kidney Neoplasms; Mice; Mice, Inbred C3H; Mitomycin; Urinary Bladder Neoplasms; Vinblastine | 1996 |
Sister-chromatid exchanges (SCE) induction by inhibitors of DNA topoisomerases in cultured human lymphocytes.
Topics: Amsacrine; Camptothecin; Cells, Cultured; Enzyme Inhibitors; Etoposide; Humans; Lymphocytes; Mitomycin; Nalidixic Acid; Sister Chromatid Exchange; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1996 |
[Effects of chemotherapy on the basis of the results of MTT assay for patients with gastrointestinal cancer].
Topics: Antineoplastic Agents; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Fluorouracil; Gastrointestinal Neoplasms; Humans; Mitomycin; Prospective Studies; Tumor Cells, Cultured | 1995 |
[Chemohyperthermic peritoneal perfusion and high-dose chemotherapy followed by peripheral blood stem cell transplantation in advanced colon cancer--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Colonic Neoplasms; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Hyperthermia, Induced; Liver Neoplasms; Lung Neoplasms; Middle Aged; Mitomycin; Perfusion; Peritoneum | 1996 |
[A case of advanced gastric cancer showing complete disappearance of cancer cells in multiple liver metastases due to low-dose PMUE therapy].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Gastrectomy; Humans; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Mitomycin; Stomach Neoplasms; Tegafur; Uracil | 1996 |
"MECCA": a developmental, dose-intensive, non-cross-resistant platinum-based chemotherapy for advanced ovarian cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Mitomycin; Neoplasm Staging; Ovarian Neoplasms | 1996 |
In vitro chemosensitivity of human pancreatic cancer cell lines.
Topics: Aged; Antimetabolites; Antineoplastic Agents; Carcinoma, Ductal, Breast; Cisplatin; DNA Replication; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Pancreatic Neoplasms; Time Factors; Toxicity Tests; Tumor Cells, Cultured | 1996 |
Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines.
Topics: Antineoplastic Agents; Cisplatin; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Etoposide; Female; Glutathione; Humans; Mitomycin; Ovarian Neoplasms; Paclitaxel; Regression Analysis; Tumor Cells, Cultured | 1997 |
The multidrug resistance-associated protein gene confers drug resistance in human gastric and colon cancers.
Topics: Antineoplastic Agents; Camptothecin; Cisplatin; Colonic Neoplasms; Doxorubicin; Etoposide; Genes, MDR; Humans; Irinotecan; Mitomycin; Polymerase Chain Reaction; RNA, Messenger; Stomach Neoplasms; Tumor Cells, Cultured; Verapamil; Vincristine | 1996 |
Mechanism of increased sensitivity to etoposide in a mitomycin C-resistant human bladder cancer cell line.
Topics: Antineoplastic Agents, Phytogenic; DNA Topoisomerases, Type II; Drug Resistance, Neoplasm; Etoposide; Humans; Mitomycin; Tumor Cells, Cultured; Tumor Stem Cell Assay; Urinary Bladder Neoplasms | 1997 |
In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia.
Topics: Aclarubicin; Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Bone Marrow; Cell Survival; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Follow-Up Studies; Humans; Infant; Infant, Newborn; Life Tables; Melphalan; Methotrexate; Mitomycin; Mitoxantrone; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Recurrence; Remission Induction; Tumor Cells, Cultured; Vincristine | 1997 |
The translin ring specifically recognizes DNA ends at recombination hot spots in the human genome.
Topics: Binding Sites; Biological Transport; Cell Nucleus; Chromosomes, Human, Pair 18; DNA Damage; DNA-Binding Proteins; DNA, Single-Stranded; Etoposide; Genes, bcl-2; Genome, Human; HeLa Cells; Humans; Mitomycin; Neoplasm Proteins; Protein Binding; Protein Conformation; Recombination, Genetic; Signal Transduction | 1997 |
[Neoadjuvant intra-arterial chemotherapy based on chemosensitivity tests for locally invasive bladder cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Drug Administration Schedule; Drug Screening Assays, Antitumor; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Mitomycin; Peplomycin; Prognosis; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Vinblastine | 1997 |
Determination of in vitro drug sensitivity to a panel of cystostatic drugs and interferon alpha-2b in patients with renal cell carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Carcinoma, Renal Cell; Cell Division; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Interferon alpha-2; Interferon-alpha; Kidney Neoplasms; Male; Middle Aged; Mitomycin; Recombinant Proteins; Tumor Cells, Cultured; Vinblastine; Vincristine | 1997 |
[Endoscopic findings of esophagitis in concurrent chemo-radiotherapy for lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Esophagitis; Esophagoscopy; Etoposide; Humans; Lung Neoplasms; Middle Aged; Mitomycin; Radiation Injuries; Radiotherapy; Vindesine | 1998 |
Neoadjuvant chemotherapy with mitomycin C, etoposide, and cisplatin for adenocarcinoma of the cervix.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Humans; Middle Aged; Mitomycin; Neoplasm Staging; Uterine Cervical Neoplasms | 1998 |
Nuclear foci of mammalian recombination proteins are located at single-stranded DNA regions formed after DNA damage.
Topics: Animals; Cell Cycle; Cell Line; Cell Nucleus; Chromatin; Cycloheximide; Dactinomycin; DNA Damage; DNA, Single-Stranded; Etoposide; Fibroblasts; Gamma Rays; Humans; Kinetics; Mammals; Meiosis; Mitomycin; Nuclear Proteins; Rats; Recombinant Proteins; Sensitivity and Specificity; Xeroderma Pigmentosum | 1999 |
Phthalascidin, a synthetic antitumor agent with potency and mode of action comparable to ecteinascidin 743.
Topics: Antineoplastic Agents, Alkylating; Bleomycin; Camptothecin; Cell Division; Cisplatin; Cross-Linking Reagents; Dioxoles; DNA Topoisomerases, Type I; DNA, Neoplasm; Doxorubicin; Etoposide; Female; Humans; Isoquinolines; Male; Mitomycin; Models, Molecular; Molecular Structure; Neoplasm Proteins; Paclitaxel; Phthalimides; Structure-Activity Relationship; Tetrahydroisoquinolines; Trabectedin; Tumor Cells, Cultured | 1999 |
Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction.
Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; Caspase 8; Caspase 9; Caspases; Cycloheximide; Cysteine Proteinase Inhibitors; Daunorubicin; Doxorubicin; Enzyme Activation; Etoposide; Fas Ligand Protein; fas Receptor; HeLa Cells; Humans; Jurkat Cells; Membrane Glycoproteins; Mitomycin; Recombinant Fusion Proteins; T-Lymphocytes; Transfection; Tumor Cells, Cultured | 1999 |
Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis.
Topics: Amino Acid Chloromethyl Ketones; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptotic Protease-Activating Factor 1; Arabidopsis Proteins; Brefeldin A; Caspase 3; Caspase 8; Caspase 9; Caspases; Cysteine Proteinase Inhibitors; Cytochrome c Group; Drug Synergism; Enzyme Activation; Enzyme Precursors; Etoposide; fas Receptor; Fatty Acid Desaturases; Humans; Jurkat Cells; Leukemia-Lymphoma, Adult T-Cell; Leukemia, B-Cell; Mitochondria; Mitomycin; Neoplasm Proteins; Plant Preparations; Plant Proteins; Proteins; Ribosome Inactivating Proteins, Type 2; Toxins, Biological; Tumor Cells, Cultured | 1999 |
[A case report: modified PMUE therapy might be effective for advanced gastric carcinoma with pulmonary carcinomatous lymphangitis].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Fluorouracil; Humans; Lung Neoplasms; Lymphangitis; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Stomach Neoplasms | 1999 |
Inversion due to intrachromosomal recombination produced by carcinogens in a transgenic mouse model.
Topics: Animals; Carcinogens; Cells, Cultured; Chromosome Inversion; Chromosomes; Escherichia coli; Etoposide; Gene Expression Regulation; Lac Operon; Methylene Chloride; Mice; Mice, Transgenic; Mitomycin; Mutagenesis; Recombination, Genetic; Spleen | 1999 |
Immortalization and characterization of Nijmegen Breakage syndrome fibroblasts.
Topics: Abnormalities, Multiple; Antineoplastic Agents; Bleomycin; Camptothecin; Cell Line; Cell Line, Transformed; Cell Survival; Cell Transformation, Viral; Child, Preschool; Chromosome Breakage; DNA; DNA Damage; DNA Repair; Etoposide; Fibroblasts; HeLa Cells; Humans; Mitomycin; Mutation; Syndrome; X-Rays | 1999 |
The effects of two different cisplatin-based chemotherapy regimens on advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Lung Neoplasms; Male; Middle Aged; Mitomycin; Retrospective Studies; Survival Rate | 1999 |
Prediction of the chemosensitivity of lung cancer by 99mTc-hexakis-2-methoxyisobutyl isonitrile SPECT.
Topics: Aged; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Etoposide; Female; Humans; Lung Neoplasms; Male; Mitomycin; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1999 |
The isolation and genetic analysis of V79-derived etoposide sensitive Chinese hamster cell mutants: two new complementation groups of etoposide sensitive mutants.
Topics: Animals; Camptothecin; Cell Separation; CHO Cells; Cricetinae; Doxorubicin; Etoposide; Genetic Complementation Test; Mitomycin; Mutation; Nucleic Acid Hybridization; Streptonigrin; Topoisomerase II Inhibitors | 1999 |
[A long-term survivor of extensive-stage small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Remission Induction; Survivors; Vindesine | 2000 |
[A case of stage IVb (H2P0N4T4) gastric cancer successfully treated with neoadjuvant chemotherapy (PMFE therapy)].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Fluorouracil; Gastrectomy; Humans; Male; Mitomycin; Neoadjuvant Therapy; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 2000 |
[Histoculture drug response assay on non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Female; Fluorouracil; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Mitomycin; Tumor Cells, Cultured | 2000 |
Human papillomavirus type 16 E6 and HPV-16 E6/E7 sensitize human keratinocytes to apoptosis induced by chemotherapeutic agents: roles of p53 and caspase activation.
Topics: Apoptosis; Atractyloside; Base Sequence; Butyric Acid; Caspases; Cells, Cultured; Cisplatin; DNA Primers; Enzyme Activation; Etoposide; Humans; Keratinocytes; Mitomycin; Oncogene Proteins, Viral; Papillomavirus E7 Proteins; Repressor Proteins; Transformation, Genetic; Tumor Suppressor Protein p53 | 2000 |
Antitumor effect of oxycellulose as a hemostatic during operation.
Topics: Animals; Antineoplastic Agents; Cell Division; Colonic Neoplasms; DNA, Neoplasm; Erythrocytes; Etoposide; Female; Fibrosarcoma; Hemostatics; Hypromellose Derivatives; Injections, Intraperitoneal; Liver Neoplasms, Experimental; Methylcellulose; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mitomycin; Tumor Cells, Cultured | 1998 |
In vitro synergistic effects of vinflunine, a novel fluorinated vinca alkaloid, in combination with other anticancer drugs.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Cell Division; Cisplatin; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Etoposide; Fluorouracil; Gemcitabine; Humans; Mitomycin; Models, Chemical; Paclitaxel; Tumor Cells, Cultured; Vinblastine; Vinorelbine | 2000 |
Isolation of camptothecin-sensitive chinese hamster cell mutants: phenotypic heterogeneity within the ataxia telangiectasia-like XRCC8 (irs2) complementation group.
Topics: Alkylating Agents; Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Bleomycin; Camptothecin; Cell Cycle; Cell Cycle Proteins; Cell Line; Cricetinae; DNA Repair; DNA-Binding Proteins; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Doxorubicin; Enzyme Inhibitors; Etoposide; Gamma Rays; Genes, Dominant; Genetic Complementation Test; Mitomycin; Mutation; Nucleic Acid Synthesis Inhibitors; Phenotype; Protein Serine-Threonine Kinases; Streptonigrin; Tumor Suppressor Proteins | 2000 |
RB-dependent S-phase response to DNA damage.
Topics: Animals; Carrier Proteins; Cell Cycle Proteins; Cell Death; Cisplatin; Cyclin A; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA; DNA Damage; DNA Replication; DNA-Binding Proteins; E2F Transcription Factors; Etoposide; Fibroblasts; Flow Cytometry; Fluorescent Antibody Technique; Gene Deletion; Mice; Mice, Knockout; Mitomycin; Mutagenicity Tests; Phosphorylation; Rats; Retinoblastoma Protein; Retinoblastoma-Binding Protein 1; S Phase; Transcription Factor DP1; Transcription Factors | 2000 |
[Hepatic arterial infusion chemotherapy using totally implantable port system].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin | 2000 |
Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis.
Topics: Adenocarcinoma; Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; bcl-X Protein; BH3 Interacting Domain Death Agonist Protein; Breast Neoplasms; Carrier Proteins; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 3; Caspase 8; Caspase 9; Caspases; Cysteine Proteinase Inhibitors; Enzyme Activation; Enzyme Precursors; Etoposide; fas Receptor; Humans; Intracellular Signaling Peptides and Proteins; Jurkat Cells; Mitochondria; Mitomycin; Neoplasm Proteins; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured | 2000 |
Metastatic carcinoma in a transposed ovary after radical hysterectomy for a stage 1B cervical adenosquamous cell carcinoma. Case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Cisplatin; Etoposide; Female; Humans; Hysterectomy; Mitomycin; Ovarian Neoplasms; Ovariectomy; Ovary; Uterine Cervical Neoplasms | 2000 |
[Postoperative complications after radiochemotherapy or chemotherapy for bronchial cancers].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Fistula; Carcinoma, Bronchogenic; Cause of Death; Cisplatin; Etoposide; Female; Fluorouracil; Hospital Mortality; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Pneumonectomy; Pneumonia; Radiotherapy, Adjuvant; Reoperation; Retrospective Studies; Risk Factors; Treatment Outcome; Vinblastine; Vindesine; Vinorelbine | 2000 |
Advanced adenocarcinoma of the urinary bladder successfully treated by the combination of cisplatinum, mitomycin-C, etoposide and tegafur-uracil chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Middle Aged; Mitomycin; Neoplasm Staging; Remission Induction; Tegafur; Urinary Bladder Neoplasms | 2001 |
Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation.
Topics: Antineoplastic Agents; Apoptosis; Caspases; Enzyme Activation; Etoposide; fas Receptor; HeLa Cells; Humans; Immunoblotting; Jurkat Cells; Mitochondria; Mitomycin; Neoplasms; Signal Transduction; Staurosporine; Transfection; Tumor Cells, Cultured | 2001 |
The adapter protein apoptotic protease-activating factor-1 (Apaf-1) is proteolytically processed during apoptosis.
Topics: Adenosine Triphosphate; Apoptosis; Apoptotic Protease-Activating Factor 1; Caspase 3; Caspase 6; Caspase 8; Caspase 9; Caspases; Cytochrome c Group; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Etoposide; fas Receptor; HeLa Cells; Humans; Immunoblotting; Jurkat Cells; Mitomycin; Models, Biological; Mutation; Nucleic Acid Synthesis Inhibitors; Protein Binding; Protein Structure, Tertiary; Proteins; Repetitive Sequences, Amino Acid; Staurosporine; Time Factors | 2001 |
Cutaneous metastases from gastric adenocarcinoma treated with combination chemotherapy producing complete response with long survival.
Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Etoposide; Female; Humans; Mitomycin; Skin Neoplasms; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 2001 |
Perturbation of SUMOlation enzyme Ubc9 by distinct domain within nucleoporin RanBP2/Nup358.
Topics: Active Transport, Cell Nucleus; Amino Acid Motifs; Amino Acid Sequence; Animals; Cell Line; Cell Nucleus; COS Cells; Cricetinae; Cytoplasm; DNA-Binding Proteins; Etoposide; Fluorescent Antibody Technique, Indirect; Glutathione Transferase; Green Fluorescent Proteins; Humans; Ligases; Luminescent Proteins; Microscopy, Fluorescence; Mitomycin; Molecular Chaperones; Molecular Sequence Data; Nuclear Pore Complex Proteins; Precipitin Tests; Protein Binding; Protein Structure, Tertiary; Protein Transport; Rad51 Recombinase; Recombinant Fusion Proteins; Recombination, Genetic; Small Ubiquitin-Related Modifier Proteins; Transfection; Ubiquitin-Conjugating Enzymes; Xenopus; Xenopus Proteins | 2002 |
Expression level of c-FLIP versus Fas determines susceptibility to Fas ligand-induced cell death in murine thymoma EL-4 cells.
Topics: Animals; Apoptosis; Camptothecin; Carrier Proteins; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase Inhibitors; Cell Membrane; Cycloheximide; Down-Regulation; Doxorubicin; Etoposide; Fas Ligand Protein; fas Receptor; Gene Expression; Intracellular Signaling Peptides and Proteins; Membrane Glycoproteins; Mice; Mitomycin; Protein Synthesis Inhibitors; Thymoma; Transcriptional Activation; Transfection; Tumor Cells, Cultured; Up-Regulation | 2002 |
Sensitivity to anticancer agents and resistance mechanisms in clear cell carcinoma of the ovary.
Topics: Adenocarcinoma, Clear Cell; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Camptothecin; Cisplatin; Coloring Agents; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Etoposide; Female; Glutathione; Humans; Inhibitory Concentration 50; Irinotecan; Mitochondrial Proteins; Mitomycin; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Ovarian Neoplasms; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; Ribosomal Proteins; RNA, Messenger; Saccharomyces cerevisiae Proteins; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2002 |
Mutagenicity of gamma-radiation, mitomycin C, and etoposide in the Hprt and Tk genes of Tk(+/-) mice.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Cells, Cultured; DNA; DNA Replication; Etoposide; Female; Gamma Rays; Hypoxanthine Phosphoribosyltransferase; Loss of Heterozygosity; Male; Mice; Mice, Knockout; Mitomycin; Mutagenicity Tests; Thymidine Kinase | 2002 |
[A cross drug resistance of mammalian cells with a high efficiency of "DNA clearing"].
Topics: Animals; Benzimidazoles; CHO Cells; Cricetinae; Cross-Linking Reagents; DNA; DNA Damage; Drug Resistance, Multiple; Enzyme Inhibitors; Ethidium; Etoposide; Fluorescent Dyes; Mitomycin; Nucleic Acid Synthesis Inhibitors | 2002 |
Chromosomal instability in B-lymphoblasotoid cell lines from Werner and Bloom syndrome patients.
Topics: 4-Nitroquinoline-1-oxide; B-Lymphocytes; Bloom Syndrome; Camptothecin; Carcinogens; Case-Control Studies; Cell Division; Cell Line; Chromosome Aberrations; Etoposide; Herpesvirus 4, Human; Humans; Karyotyping; Metaphase; Micronuclei, Chromosome-Defective; Mitomycin; Sister Chromatid Exchange; Werner Syndrome | 2002 |
Catalase protects HepG2 cells from apoptosis induced by DNA-damaging agents by accelerating the degradation of p53.
Topics: Adenoviridae; Apoptosis; Catalase; Cell Line; DNA Damage; DNA, Complementary; Etoposide; Gene Expression Regulation, Enzymologic; Genes, p53; Humans; Mitomycin; Nucleic Acid Synthesis Inhibitors; Oxidative Stress; Transfection | 2003 |
[Radio-chemotherapy combination in locally advanced, inoperable, non-small cell bronchial cancers].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Humans; Lung Neoplasms; Mitomycin; Neoplasm Staging; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vinblastine; Vindesine; Vinorelbine | 2002 |
Etoposide and merbarone are clastogenic and aneugenic in the mouse bone marrow micronucleus test complemented by fluorescence in situ hybridization with the mouse minor satellite DNA probe.
Topics: Aneugens; Aneuploidy; Animals; Antibiotics, Antineoplastic; Bone Marrow; Chromosomes; Colchicine; DNA Probes; DNA, Satellite; Enzyme Inhibitors; Erythrocytes; Etoposide; Gout Suppressants; In Situ Hybridization, Fluorescence; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C3H; Micronucleus Tests; Mitomycin; Mutagens; Thiobarbiturates; Topoisomerase II Inhibitors | 2003 |
[The role of surgical therapy for esophageal microcytoma. Experience of there clinical cases and results analysis].
Topics: Aged; Anastomosis, Surgical; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Esophagoplasty; Esophagoscopy; Etoposide; Fatal Outcome; Female; Humans; Laparotomy; Lymph Node Excision; Male; Middle Aged; Mitomycin; Remission Induction; Stomach; Thoracotomy; Vinblastine; Vinorelbine | 2003 |
A young woman with clear cell adenocarcinoma of the uterine cervix.
Topics: Adenocarcinoma, Clear Cell; Adolescent; Age of Onset; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinogens; Diethylstilbestrol; Etoposide; Female; Humans; Hysterectomy; Japan; Lymph Node Excision; Mitomycin; Neoadjuvant Therapy; Netherlands; Prognosis; Uterine Cervical Neoplasms | 2003 |
[Metastatic cancer in transposed ovaries after radical Wertheim-Meigs hysterectomy for a stage I B and II A cervical cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Cisplatin; Etoposide; Female; Humans; Hysterectomy; Mitomycin; Neoplasm Staging; Ovarian Neoplasms; Ovary; Treatment Outcome; Uterine Cervical Neoplasms | 2003 |
Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin.
Topics: Animals; Annexin A5; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Body Weight; Camptothecin; Cell Line, Tumor; Cisplatin; Coloring Agents; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Etoposide; Heme Oxygenase (Decyclizing); Humans; Hydrogen Peroxide; Male; Metalloporphyrins; Mice; Mitomycin; Neoplasms; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxygen; Polyethylene Glycols; Proline; Reactive Oxygen Species; Tetrazolium Salts; Thiazoles | 2004 |
Targeted disruption of one allele of the Y-box binding protein-1 (YB-1) gene in mouse embryonic stem cells and increased sensitivity to cisplatin and mitomycin C.
Topics: Alleles; Animals; Antineoplastic Agents, Alkylating; CCAAT-Enhancer-Binding Proteins; Cells, Cultured; Cisplatin; Colony-Forming Units Assay; DNA Damage; Drug Resistance, Neoplasm; Embryo, Mammalian; Etoposide; Gene Targeting; Heterozygote; Mice; Mitomycin; NFI Transcription Factors; RNA, Messenger; Stem Cells; Transcription Factors; Ultraviolet Rays; Y-Box-Binding Protein 1 | 2004 |
A novel mammalian cell-based approach for the discovery of anticancer drugs with reduced cytotoxicity on non-dividing cells.
Topics: Animals; Antineoplastic Agents; Biological Assay; Cell Cycle Proteins; Cell Division; Cell Survival; CHO Cells; Cricetinae; Cyclin-Dependent Kinase Inhibitor p27; Doxorubicin; Drug Design; Drug Screening Assays, Antitumor; Etoposide; Fluorescent Antibody Technique; Fluorouracil; Mitomycin; Transfection; Tumor Suppressor Proteins | 2004 |
Augmentation of chemotherapy-induced cytokine production by expression of the platelet-activating factor receptor in a human epithelial carcinoma cell line.
Topics: Adjuvants, Immunologic; Antineoplastic Agents; Antioxidants; Carcinoma, Squamous Cell; Chromans; Cytokines; Etoposide; Humans; Interleukin-8; KB Cells; Mitomycin; NF-kappa B; Oxidative Stress; Phospholipid Ethers; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; RNA, Messenger; Signal Transduction; Tetradecanoylphorbol Acetate; Transduction, Genetic | 2004 |
Dependence of the cytotoxicity of DNA-damaging agents on the mismatch repair status of human cells.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Base Pair Mismatch; Camptothecin; Carrier Proteins; Cell Line; Cisplatin; DNA Repair; Drug Screening Assays, Antitumor; Etoposide; Furocoumarins; Humans; Inhibitory Concentration 50; Melphalan; Mitomycin; MutL Protein Homolog 1; Neoplasm Proteins; Nitrosourea Compounds; Nuclear Proteins | 2004 |
A pilot study of neoadjuvant chemotherapy with mitomycin C, etoposide, cisplatin, and epirubicin for adenocarcinoma of the cervix.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Chemotherapy, Adjuvant; Cisplatin; Dose-Response Relationship, Drug; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Radiotherapy, Adjuvant; Statistics as Topic; Treatment Outcome; Uterine Cervical Neoplasms; Women's Health | 2004 |
Relative cytotoxicity values at the lowest effective concentration for 12 positive chemicals in the in vitro micronucleus test utilizing Chinese hamster ovary cells.
Topics: Animals; Benz(a)Anthracenes; Bleomycin; Cell Count; Cell Survival; CHO Cells; Cricetinae; Cricetulus; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Drug; Etoposide; Female; Griseofulvin; Hazardous Substances; Hydrogen Peroxide; Hydroxyurea; Methyl Methanesulfonate; Mitomycin; Phenol; Vinblastine | 2004 |
Detection of a mouse OGG1 fragment during caspase-dependent apoptosis: oxidative DNA damage and apoptosis.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Caspases; Cell Nucleus; DNA Damage; DNA Glycosylases; DNA Repair; Etoposide; Hepatocytes; Immunoblotting; Mice; Mitomycin; Oxidative Stress; Tumor Cells, Cultured | 2004 |
The DNA double-stranded break repair protein endo-exonuclease as a therapeutic target for cancer.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Survival; Cisplatin; Coloring Agents; DNA; DNA Damage; DNA Repair; Down-Regulation; Drug Evaluation, Preclinical; Endonucleases; Etoposide; Exonucleases; Fluorouracil; HeLa Cells; Humans; Kinetics; Mice; Mitomycin; Neoplasms; Pentamidine; Plasmids; Recombination, Genetic; RNA, Small Interfering; Tetrazolium Salts; Thiazoles; Time Factors | 2004 |
[A case of advanced gastric cancer with peritonitis carcinomatosa resected with intraperitoneal chemotherapy based on chemosensitivity test with ascites].
Topics: Antineoplastic Combined Chemotherapy Protocols; Ascites; Ascitic Fluid; Cisplatin; Drug Administration Schedule; Drug Screening Assays, Antitumor; Etoposide; Humans; Injections, Intraperitoneal; Male; Middle Aged; Mitomycin; Peritoneal Neoplasms; Peritonitis; Stomach Neoplasms; Tegafur; Tumor Cells, Cultured; Uracil | 2004 |
DNA lesion-specific co-localization of the Mre11/Rad50/Nbs1 (MRN) complex and replication protein A (RPA) to repair foci.
Topics: Acid Anhydride Hydrolases; Blotting, Western; Camptothecin; Cations; Cell Cycle Proteins; Cell Nucleus; Comet Assay; DNA; DNA Damage; DNA Repair; DNA Repair Enzymes; DNA-Binding Proteins; DNA, Single-Stranded; Etoposide; HeLa Cells; Humans; Hydroxyurea; Macromolecular Substances; Microscopy, Fluorescence; Mitomycin; Models, Biological; MRE11 Homologue Protein; Multiprotein Complexes; Nuclear Proteins; Phosphorylation; Protein Binding; Replication Protein A; Time Factors | 2005 |
Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Intraoperative Care; Male; Middle Aged; Mitomycin; Peritoneum; Postoperative Complications; Stomach Neoplasms; Survival Analysis | 2005 |
Detection of numerical chromosomal aberrations by flow cytometry: a novel process for identifying aneugenic agents.
Topics: Adult; Aneugens; Cells, Cultured; Chromosome Aberrations; Etoposide; Female; Flow Cytometry; Griseofulvin; Humans; Lymphocytes; Male; Mitomycin; Mitosis; Mutagenicity Tests; Paclitaxel; Polyploidy | 2005 |
Clinical responses of large cell neuroendocrine carcinoma of the lung to cisplatin-based chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Treatment Outcome; Vindesine | 2005 |
In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor.
Topics: Animals; Antineoplastic Agents; Apoptosis; BRCA2 Protein; Caspases; Cell Cycle; Cell Line, Tumor; Cell Survival; Chlorambucil; Cisplatin; Cross-Linking Reagents; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Fanconi Anemia Complementation Group C Protein; Fanconi Anemia Complementation Group G Protein; Fanconi Anemia Complementation Group Proteins; Female; Fluorouracil; Gemcitabine; Humans; Inhibitory Concentration 50; Melphalan; Mice; Mice, Nude; Mitomycin; Mutation; Paclitaxel; Pancreatic Neoplasms; Time Factors; Vinblastine; Xenograft Model Antitumor Assays | 2005 |
Optimal combination chemotherapy and chemoradiotherapy with etoposide for advanced cervical squamous cancer cells in vitro.
Topics: Antigens, CD20; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Squamous Cell; CD40 Antigens; Cell Survival; Clone Cells; Combined Modality Therapy; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Resistance, Neoplasm; Etoposide; Female; Flow Cytometry; Fluorouracil; Humans; Integrin alpha1; Integrin alpha6; Irinotecan; Mitomycin; Uterine Cervical Neoplasms; X-Rays | 2006 |
hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Catalytic Domain; Cell Line, Tumor; Cell Survival; Cisplatin; Colonic Neoplasms; DNA-Binding Proteins; Etoposide; fas Receptor; Female; Humans; Mitochondria; Mitomycin; Reactive Oxygen Species; Telomerase; Uterine Cervical Neoplasms | 2006 |
[Current data concerning neoadjuvant chemotherapy].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Ifosfamide; Lung; Lung Neoplasms; Mitomycin; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Radiotherapy Dosage; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Risk; Time Factors | 2006 |
[Comparing cisplatin plus etoposide with combination of mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Retrospective Studies; Survival Analysis; Treatment Outcome; Turkey | 2006 |
Antioxidant function of corneal ALDH3A1 in cultured stromal fibroblasts.
Topics: Aldehyde Dehydrogenase; Aldehydes; Animals; Antibiotics, Antineoplastic; Antioxidants; Cell Line; Cell Survival; Chromatography, High Pressure Liquid; Cornea; DNA Damage; Etoposide; Fibroblasts; Glutathione; Humans; Lipid Peroxidation; Mitomycin; Oxidative Stress; Rabbits; Stromal Cells; Transfection | 2006 |
[A case of non-small cell lung cancer in which complete response was achieved with chemotherapy including cisplatin, vinorelbine, mitomycin C, followed by additional cisplatin, etoposide and concurrent radiotherapy].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Humans; Lung Neoplasms; Male; Mitomycin; Neoplasm Staging; Pneumonectomy; Remission Induction; Vinblastine; Vinorelbine | 2006 |
Calreticulin exposure dictates the immunogenicity of cancer cell death.
Topics: Animals; Anthracyclines; Antigens, Differentiation; Antineoplastic Agents; Apoptosis; Calreticulin; Cell Cycle Proteins; Cell Line, Tumor; Cell Membrane; Colonic Neoplasms; Dendritic Cells; Electrophoresis, Gel, Two-Dimensional; Etoposide; Immunoblotting; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Neoplasms, Experimental; Phagocytosis; Protein Phosphatase 1; Protein Transport; Recombinant Proteins; RNA Interference | 2007 |
Evidence of a novel antiapoptotic factor: role of inhibitor of differentiation or DNA binding (Id-1) in anticancer drug-induced apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Catechin; Cell Line, Tumor; Cell Survival; Cisplatin; Down-Regulation; Doxorubicin; Etoposide; Female; HeLa Cells; Humans; Inhibitor of Differentiation Protein 1; Liver Neoplasms; Male; Mechlorethamine; Methotrexate; Mitomycin; Nasopharyngeal Neoplasms; Paclitaxel; Prostatic Neoplasms; Vincristine | 2007 |
Calreticulin exposure increases cancer immunogenicity.
Topics: Animals; Anthracyclines; Antigens, Differentiation; Antineoplastic Agents; Apoptosis; Calreticulin; Cell Cycle Proteins; Cell Line, Tumor; Cell Membrane; Colonic Neoplasms; Dendritic Cells; Electrophoresis, Gel, Two-Dimensional; Etoposide; Immunoblotting; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Neoplasms, Experimental; Phagocytosis; Protein Phosphatase 1; Protein Transport; Recombinant Proteins; RNA Interference | 2007 |
A novel form of ataxia oculomotor apraxia characterized by oxidative stress and apoptosis resistance.
Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Apraxias; Ataxia; Blotting, Western; Camptothecin; Cells, Cultured; DNA Breaks, Single-Stranded; DNA Damage; DNA Repair; Etoposide; Female; Flow Cytometry; Humans; Hydrogen Peroxide; Male; Membrane Potential, Mitochondrial; Methylnitronitrosoguanidine; Mitomycin; Oxidative Stress; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Radiation, Ionizing; Reactive Nitrogen Species | 2007 |
Long-term survival of resectable subset after induction chemotherapy in patients with locally advanced head and neck cancer.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma; Cisplatin; Etoposide; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mitomycin; Neoadjuvant Therapy; Prognosis; Radiotherapy, Adjuvant; Survival Analysis; Vincristine | 2008 |
[Chemotherapy of advanced non small cell lung cancer: effect on survival and symptoms affecting quality of life].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Poland; Quality of Life; Retrospective Studies; Survival Analysis; Treatment Outcome; Vinblastine | 2007 |
miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Cisplatin; Down-Regulation; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Fluorouracil; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Humans; Microarray Analysis; MicroRNAs; Mitomycin; Proto-Oncogene Proteins c-bcl-2; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; Stomach Neoplasms; Up-Regulation; Vincristine | 2008 |
Human T-cell leukemia virus I tax protein sensitizes p53-mutant cells to DNA damage.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Cell Cycle; Cells, Cultured; Dimerization; DNA Damage; Etoposide; Fibroblasts; Gene Products, tax; Humans; Immunoblotting; Luciferases; Mice; Mitomycin; Mutation; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Ultraviolet Rays; Vinblastine | 2008 |
A syngeneic variance library for functional annotation of human variation: application to BRCA2.
Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Cells, Cultured; Chromosomal Instability; Clone Cells; Drug Resistance, Neoplasm; Etoposide; Gene Library; Genes, BRCA2; Genetic Variation; Humans; Mitomycin; Models, Biological; Mutagenesis, Site-Directed; Rad51 Recombinase; Tumor Stem Cell Assay | 2008 |
Premature senescence is a major response to DNA cross-linking agents in BRCA1-defective cells: implication for tailored treatments of BRCA1 mutation carriers.
Topics: Aging, Premature; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; BRCA1 Protein; Breast Neoplasms; Cell Line, Transformed; Cells, Cultured; Cellular Senescence; Cisplatin; Colony-Forming Units Assay; Cross-Linking Reagents; Doxorubicin; Etoposide; Humans; Mitomycin | 2009 |
The cellular phenotype of Roberts syndrome fibroblasts as revealed by ectopic expression of ESCO2.
Topics: Acetyltransferases; Camptothecin; Cell Cycle Proteins; Chromosomal Proteins, Non-Histone; Chromosome Aberrations; Chromosome Segregation; Cohesins; Congenital Abnormalities; DNA Damage; Etoposide; Fibroblasts; Growth Disorders; Humans; Infant; Male; Mitomycin; Nucleic Acid Synthesis Inhibitors; Sister Chromatid Exchange; Syndrome | 2009 |
Chemotherapy induces ATP release from tumor cells.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Apoptosis; Cadmium; Cell Line, Tumor; Cisplatin; Etoposide; Flow Cytometry; Fluorescent Antibody Technique; Mice; Mitomycin; Mitoxantrone; Neoplasms; Organoplatinum Compounds; Oxaliplatin; Sphingosine; Thapsigargin | 2009 |
Etoposide; colchicine; mitomycin C and cyclophosphamide tested in the in vitro mammalian cell micronucleus test (MNvit) in Chinese hamster lung (CHL) cells at Covance laboratories; Harrogate UK in support of OECD draft Test Guideline 487.
Topics: Animals; Cell Count; Cell Death; Cell Line; Cell Proliferation; Colchicine; Cricetinae; Cricetulus; Cyclophosphamide; Cytochalasin B; Etoposide; Guidelines as Topic; Lung; Micronucleus Tests; Mitomycin; Mutagens | 2010 |
Mitomycin C, 5-fluoruracil, colchicine and etoposide tested in the in vitro mammalian cell micronucleus test (MNvit) in the human lymphoblastoid cell line TK6 at Novartis in support of OECD draft Test Guideline 487.
Topics: Cell Count; Cell Line; Cell Proliferation; Colchicine; Cytochalasin B; Cytokinesis; Etoposide; Fluorouracil; Guidelines as Topic; Humans; Lymphocytes; Micronucleus Tests; Mitomycin; Mutagens; Switzerland | 2010 |
Inhibition of hypoxia-inducible factor-1alpha (HIF-1alpha) protein synthesis by DNA damage inducing agents.
Topics: 5' Untranslated Regions; Apoptosis; Camptothecin; Cell Hypoxia; Cell Line; Cyclin-Dependent Kinases; DNA Damage; Etoposide; Eukaryotic Initiation Factor-2; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mitomycin; Phosphorylation; Protein Biosynthesis; Protein Processing, Post-Translational; Signal Transduction; Transcription, Genetic; Tumor Suppressor Protein p53 | 2010 |
Combinatory cytotoxic effects produced by E1B-55kDa-deleted adenoviruses and chemotherapeutic agents are dependent on the agents in esophageal carcinoma.
Topics: Adenoviridae; Adenovirus E1B Proteins; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Esophageal Neoplasms; Etoposide; Female; Fluorouracil; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Oncolytic Virotherapy; Virus Replication | 2010 |
Etoposide, mitomycin, and methotrexate combination in heavily treated breast cancer: a retrospective study.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Etoposide; Female; Humans; Methotrexate; Middle Aged; Mitomycin; Retrospective Studies; Survival Rate | 2012 |
An evolutionarily acquired genotoxic response discriminates MyoD from Myf5, and differentially regulates hypaxial and epaxial myogenesis.
Topics: Animals; Ataxia Telangiectasia Mutated Proteins; Biological Evolution; Cell Cycle Proteins; Cell Differentiation; Cells, Cultured; Coculture Techniques; Cross-Linking Reagents; DNA Damage; DNA-Binding Proteins; Etoposide; Female; Gene Knockdown Techniques; Methyl Methanesulfonate; Mice; Mitomycin; Muscle Development; Mutagens; MyoD Protein; Myogenic Regulatory Factor 5; Phosphorylation; Pregnancy; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-abl; RNA Interference; Somites; Tumor Suppressor Proteins | 2011 |
Interlaboratory assessment of mitotic index by flow cytometry confirms superior reproducibility relative to microscopic scoring.
Topics: Adult; Benzo(a)pyrene; Chromosome Aberrations; Cyclophosphamide; Etoposide; Flow Cytometry; Humans; Lymphocytes; Mitomycin; Mitotic Index; Regression Analysis | 2012 |
p21 promotes error-free replication-coupled DNA double-strand break repair.
Topics: Animals; BRCA2 Protein; Camptothecin; Chromosomal Instability; Cross-Linking Reagents; Cyclin-Dependent Kinase Inhibitor p21; DNA Breaks, Double-Stranded; DNA End-Joining Repair; DNA Repair; DNA Repair Enzymes; DNA Replication; DNA-Binding Proteins; Etoposide; G1 Phase Cell Cycle Checkpoints; HCT116 Cells; HeLa Cells; Humans; Mice; Mitomycin; MRE11 Homologue Protein; Phosphorylation; Recombinational DNA Repair; Topoisomerase Inhibitors | 2012 |
Targeting the IL-4/IL-13 signaling pathway sensitizes Hodgkin lymphoma cells to chemotherapeutic drugs.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-X Protein; Cell Line, Tumor; Doxorubicin; Enzyme Activation; Etoposide; Fluorouracil; Hodgkin Disease; Humans; Interleukin-13; Interleukin-4; Mitomycin; Paclitaxel; Promoter Regions, Genetic; Reed-Sternberg Cells; RNA Interference; RNA, Small Interfering; Signal Transduction; STAT6 Transcription Factor | 2013 |
Impact of cell cycle delay on micronucleus frequency in TK6 cells.
Topics: Apoptosis; Cell Cycle; Cell Line; Etoposide; Humans; Micronucleus Tests; Mitomycin; Mutagens; Vinblastine | 2014 |
Extraskeletal Osteosarcoma: An International Rare Cancer Network Study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Deoxycytidine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; Ifosfamide; Lower Extremity; Male; Methotrexate; Middle Aged; Mitomycin; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Osteosarcoma; Pelvic Neoplasms; Prognosis; Radiotherapy; Rare Diseases; Retroperitoneal Neoplasms; Retrospective Studies; Soft Tissue Neoplasms; Tumor Burden; Young Adult | 2016 |
Characterization of LGALS3 (galectin-3) as a player in DNA damage response.
Topics: Antineoplastic Agents; Blood Proteins; BRCA1 Protein; Carboplatin; DNA Damage; DNA Repair; Etoposide; G2 Phase Cell Cycle Checkpoints; Galectin 3; Galectins; Gene Silencing; HEK293 Cells; HeLa Cells; Humans; Mitomycin; Protein Interaction Maps; Signal Transduction; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Ubiquitination | 2014 |
The predominant role of apoptosis in γH2AX formation induced by aneugens is useful for distinguishing aneugens from clastogens.
Topics: Aneugens; Apoptosis; Cells, Cultured; DNA Damage; Etoposide; Histones; Humans; Micronucleus Tests; Mitomycin; Mutagens; Paclitaxel; Vinblastine | 2014 |
Safety of Brucea javanica and cantharidin combined with chemotherapy for treatment of NSCLC patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brucea; Cantharidin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cohort Studies; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Invasiveness; Neoplasm Staging; Patient Safety; Phytotherapy; Plant Extracts; Prognosis; Quality of Life; Retrospective Studies; Risk Assessment; Survival Analysis | 2014 |
Nkx3.1 controls the DNA repair response in the mouse prostate.
Topics: Animals; DNA; DNA Damage; DNA Repair; Etoposide; Gamma Rays; Homeodomain Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Mutant Strains; Mitomycin; Prostate; Transcription Factors | 2016 |